5-HT信号转导相关SNPs与心境障碍
|
摘要
第一部分5-HT_(2A)及其信号转导SNP_s与心境障碍的关联分析
目的:
探讨5-HT_(2A)相关转导通路上G蛋白、腺苷酸环化酶、磷酸二酯酶和cAMP反应元件结合蛋白(CREB)相关基因SNPs与心境障碍关系,分析相关基因突变合并存在时是否增加心境障碍发病风险。
方法:
1.根据美国精神障碍诊断与统计手册第四版(DSM-Ⅳ)和《中国精神障碍分类方案及诊断标准(第三版)》(CCMD-3)有关心境障碍的诊断标准,选择符合有关双相或抑郁症诊断标准的汉族患者417例(其中抑郁症326例,双相障碍91例),在相同地区范围内选择293名汉族健康对照;分别比较病例组基因型、等位基因分布差异,并与心境障碍进行关联分析。
2.采用连接酶反应技术(LDR),检测5-HT_(2A)rs6311、GNB3rs5443、ADCY9rs2230739和PDE_(1A)rs1549870等5-HT_(2A)相关信号转导的5个SNPs的基因多态性。
3.选用SPSS 11.5 for windows软件包进行数据处理。采用拟合优度卡方检验,分析基因型、等位基因频率是否符合Hardy-Weinderg平衡定律;病例和对照组的基因型和等位基因频度比较,比较采用X_2检验;选用多元回归分析、关联比(odds ratio,OR)和95%的置信区间(confidence in teval,CI)评价患病风险;显著性水平为p=0.05。
结果:
1.5个SNPs位点的检测结果:对710个汉族人DNA样本的rs6311、rs5443、rs2230739、rs 2551638和rs1549870等5个SNPs位点的检测发现,rs6311、rs5443、rs2230739和rs1549870在汉族人群中存在多态性,而CREB1rs2551638则在汉族人中不存在多态性。
2.病例组与对照组SNPs基因型频率和等位基因频率比较:417例心境障碍患者rs6311的TT、TC和CC三种基因型频率分别为0.316、0.494和0.19,其T等位基因频率为0.563,C等位基因频率为0.437;293名健康对照rs6311的TT、TC和CC三种基因型频率为0.433、0.430和0.137,其T等位基因频率为0.648,C等位基因频率为0.352;三种基因型分布存在显著性差异,病例组TI型明显减少,而CC型增多(x~2=11.003,p=0.004);病例组T等位基因频率降低,c等位基因频率增高(OR=1.434,95%CI=1.153～1.783;x~2=10.523,p=0.001)。417例心境障碍患者rs5443的TT、TC和CC三种基因型频率为0.18、0.472和0.348,其T等位基因频率为0.416,C等位基因频率为0.584;293名健康对照rs5443的TT、TC和CC三种基因型频率为0.181、0.505和0.314,其T等位基因频率为0.433,C等位基因频率为0.567;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。415例心境障碍患者rs2230739的GG、GA、AA三种基因型频率分别为0.176、0.498和0.335,其G等位基因频率为0.42,A等位基因频率为0.58;293名对照组rs2230739的GG、GA、AA三种基因型频率分别为0.119、0.515和0.365,其G等位基因频率为0.377,A等位基因频率为0.632;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。408例心境障碍患者rs1549870的GG、GA、AA三种基因型频率分别为0.49、0.426和0.083,其G等位基因频率为0.703,A等位基因频率为0.297;291名对照组rs1549870的GG、GA、AA三种基因型频率分别为0.557、0.361和0.082,其G等位基因频率为0.737,A等位基因频率为0.263;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。
3.不同亚型间SNPs基因型和等位基因分布比较:326例抑郁症患者中共有男134例,女192例,比较抑郁组与对照组比较发现,rs6311三种基因型分布存在组间显著性差异,抑郁症组TI型明显减少,而GG型增多(x~2=6.460,p=0.04),抑郁症组的T等位基因频率低于对照组,C等位基因频率则明显高于对照组(OR=1.360,95%CI 1.080～1.712;x~2=6.865,p=0.009);rs5443、rs2230739和rs1549870的基因型分布频率和等位基因频率则未见两组间存在明显差异(p＞0.05)。抑郁症组男性患者与女性患者4个SNPs基因型和等位基因分布比较,均未见明显组间差异(p＞0.05)。
91例双相障碍患者与117健康对照比较发现,rs6311三种基因型分布存在组间显著性差异,双相组TT型明显减少,而GG型增多(x~2=11.031,p=0.004、);其他位点的基因型分布频率则未见两组间存在明显差异(p＞0.05)。双相组rs6311T等位基因频率低于对照组,C等位基因频率则明显高于对照组(OR=1.735,95%CI=1.168～2.578;X~2=7.504,p=0.006);其他SNPs的两组差异未见显著性意义(p＞0.05)。
4.SNPs基因型与心境障碍的关联分析:将病例组与对照组rs6311、rs5443、rs2230739和rs1549870等4个SNPs的基因型进行关联分析发现,rs6311CC基因型患病的相对危险度为(OR=1.487,95%CI=0.983～2.249;x~2=3.561,p=0.059),TT基因型患病的相对危险度为(OR=1.659,95%CI=1.216～2.262;x~2=10.287,p=0.001)。rs5443 TF、rs5443 TC、rs2230739AA、rs2230739GA、rs1549870 GG则均未见组间差异(p＞0.05)。采用logistic回归分析,4个SNPs各基因型心境障碍关系,结果发现rs6311的TT和TC基因型进入方程,回归系数为分别为-0.618和-0.161。
5.rs6311与其他SNPs患病的联合风险:将rs6311各基因型与其他SNPs基因型的联合风险进行比较发现,rs6311的CC与rs5443TT或CC合并存在时,患病风险增加[(OR=4.838,95%CI=1.091～21.450;x~2=5.237,p=0.022)或(OR=3.329,95%CI=1.703-6.510;x~2=13.662,p=0.000)];rs6311的CC与rs2230739的GG合并时患病风险增加[(OR=3.375,95%CI=0.961～11.851,x~2=4.046,p=0.044)];rs6311 CT与rs1549870 AG合并患病风险增加[(OR=1.645,95%CI=1.107～2.444,x~2=6.313,p=0.013)]。
结论:
1.5-HT_(2A)rs6311在汉族心境障碍患者存在C等位基因频率增高,T位基因频率降低现象,且C等位基因频率增高在抑郁和双相中普遍存在,rs6311C等位基因频率升高导致患病风险增加,提示rs6311可能是5-HT_(2A)基因的高功能位点,建议将该位点作为心境障碍的标志性位点进一步研究。
2.Gβ3的rs5443和ADCY_9的rs2230739两个位点在汉族中均属高频位点,病例组与对照比较没有发现与心境障碍存在关联的证据,但当rs6311CC与rs5443TT或CC型,以及与rs2230739的GG合并存在时患病风险有明显增加趋势,提示Gβ_3和ADCY_9可能是心境障碍的微效基因之一。
3.没有发现PDE1Ars1549870与心境障碍关联的直接证据。
4.CREB1rs2551638位点在汉族患者中不存在多态性,无法依赖该位点推断CREB与心境障碍的关系。
第二部分5-HT_(2A)信号转导相关SNP_s与抑郁症表型特征的关系
目的:
探讨5-HT_(2A)信号传导通路的rs6311、rs5443、rs2230739、rs1549870等4个SNPs与抑郁症表型特征的关系,进一步论证这些SNPs与心境障碍的关系。
方法:
参照DSM-Ⅳ和CCMD-3对194例抑郁症患者临床症状,发作倾向和是否伴有精神病性症状进行分级评定,采用开放性临床治疗观察了194抑郁症患者对SSRIS的疗效,并对174例进行了为期1年以上的随访,观察其长期疗效;采用最优尺度检验分析SNPs基因型抑郁症表型特征与疗效的关系。
结果
1.四个位点与基本症状的关系:四个SNP_s基因型与基本症状的多重对应分析图显示:rs6311CC、rs5443CC与rs1549870GG与兴趣减少(基本症状2)在一个区域内,相对距离较近,其中rs5443CC与rs1549870GG距离最为接近;rs5443CT、rs1549870AG、rs2230739AG在一个区内,距离相对较近,没有发现与心境低落或可疑心境低落相关的基因型存在。
2.4个位点与附加症状的关系:4个SNPS基因型与附加症状的多重对应分析图显示:rs6311CC与自杀观念及行为在同一单位阵内,与自杀观念距离最近,rs6311TT则与无自杀者同在同一单位阵,且相距紧密;rs6311CC还与失眠症状、认识症状在一个单位阵内,rs5443CT,rs1549870AG与疲劳症状群在同一单位阵。
3.其他临床特征的关系:4个SNPS基因型与其他临床特征的多重对应分析图显示:rs6311CC与伴有精神病性症状和多次复发同在一个单位阵内,rs6311TT和少复发同在一个单位阵内;rs1549870GG与不伴精神症状同在一个单位阵内,距离较近。
4.4个位点与SSRI类疗效及长期疗效的关系:rs5443、rs2230739和SSRI疗效有关,其回归系数分别为0.181和0.283;rs2230739和长期疗效有关,其回归系数为0.400。
结论:
1.据本研究发现rs6311CC型与抑郁症的部分症状包括兴趣减少、自杀、失眠、精神病性症状和复发倾向关系密切,推测rs6311可能是5-HT_(2A)的功能位点,建议进一步探讨5-HT_(2A)rs6311T/C多态性是否属于抑郁症的生物学内表型。
2.Gβ3rs5443TT和ACDY_9rs2230739GG患者对SSRI类的短期疗效相对较好,Gβ3和ACDY_9可能是不同患者SSRIs疗效差异的分子遗传学基础。
3.ACDY_9rs2230739GG型长期抗抑郁治疗效果较好,推测ACDY_9rs2230739基因多态性可能是个体间长期疗效差异的生物学基础。
PARTⅠAssociation between the 5-HT_(2A)pathway related genes and mood disorders
Objective:
This research aims at the investigating the association between 5-HT2A pathway related genes,including G protein,adenylcyclase, phosphodiesterase or cAMP responsive element binding protein,and mood disorders.Also,the effects of the gene x gene interaction on the risk of mood disorders will be investigated.
Methods:
(1)With the case-control design,417 mood disorders and depressive disorder patients(326 depressive disorder patients,91 mood disorder patients),met the criteria of DSM-Ⅳand CCMD-3,and 293 healthy Chinese Han were recruited in Henan Province,and respectively compared distributional difference of genotype and allele between two groups,and analyzed association between SNP_s and mood disorders.
(2)Five SNPs of 5-HT2A rs6311、GNβ3rs5443、ADCY9rs2230739, PDE1Ars1549870,which were located at the genes of 5-HT_(2A)pathway, were discriminated by using the assay of LDR.
(3)Performing SPSS 11.5 package,the Hardy-Weinberg equilibrium, the distribution of the allelic and genotype frequencies among the cases and controls were analyzed by x~2 test.The morbidity risk was evaluated using 95%confidence interval,odds ratio and confidence interval.The level of significance was p=0.05.
Results:
1.The polymorphism of the five SNPs::There were polymorphism of rs6311,rs5443,rs2230739 and rs 1549870,and no polymorphism of CREB1 rs255163 among these 710 Chinese Han(417 patients with mood disorders and 293 healthy controls).
2.Comparison of genotypic/allele frequency between patients and controls:Genotypic frequencies of the wild-type homozygote(TT),TC and the mutation homozygote(CC)of rs6311 among 417 patients with mood disorders were 0.316,0.494 and 0.19 respectively,T allel frequency was 0.563,and C allel frequency was 0.437.Correspondingly in 293 healthy controls,genotypic frequencies of TT,TC and CC were 0.433, 0.430 and 0.137 respectively,T allel frequency was 0.648,and C allel frequency was 0.352.There was significant difference of genotypes distribution of rs6311 between patients and controls.The mutation homozygote(CC)frequency is significantly higher in patients than in controls,but the wild-type homozygote(TT)frequency is lower (x~2=11.003,p=0.004).Also the T allele frequency was lower and the C allelic frequency is higher in the patients(OR=1.434,95%CI=1.153～1.783;x~2=10.523,p=0.001).As for rs5443,its genotypic frequencies of TT,TC and CC in 417 patients were 0.18,0.472 and 0.348 respectively,T allel frequency was 0.416,and C allel frequency was 0.581. Correspondingly in healthy controls,its genotypic frequencies of TT, TC and CC were 0.119,0.515 and 0.365 respectively,T allel frequency was 0.433,and C allel frequency was 0.567.There were significant difference in neither genotype nor allel distribution between patients and controls(p＞0.05).Genotypic frequencies of GG,GA and AA of rs 2230739 among 415 patients with mood disorders were 0.176,0.498 and 0.335 respectively,G allel frequency was 0.563,and A allel frequency was 0.437.Correspondingly in 293 healthy controls,genotypic frequencies of GG,GA and AA of rs2230739 were 0.119,0.515 and 0.365 respectively,G allel frequency was 0.377,and A allel frequency was 0.632.There was no significant difference of genotype\allel distribution between patients and controls(p＞0.05).As for rs1549870,its genotypic frequency of GG,GA and AA among 408 patients were 0.49,0.426 and 0.083 respectively,G allel frequency was 0.703,and A allel frequency was 0.297.Correspondingly in healthy controls,its genotypic frequencies of GG,GA and AA were 0.557,0.361 and 0.082 respectively,G allel frequency was 0.737,and A allel frequency was 0.263.There were significant difference in neither genotype nor allel distribution between patients and controls(p＞0.05)
3.Comparison of genotypic and allele distribution of SNPs in different subtypes:There were significant difference in three genotype interclasses of rs6311 by comparing between control group and depressive group(326 cases,134 males,192 females).In depressive group, not only TT obviously decreased,while CC mcreased(x~2=6.460,p-0.04), but also T allele frequency of depressive group was lower,while C allele frequency was higher in depressive group(OR=1.360,95%CI=1.080～1.712;x~2= 6.865,p=0.009);There were no significant difference of genotypic \allele distribution of rs5443,rs2230739 and rs1549870 among interclasses(p＞0.05),and no significant difference genotypic\allele distribution of four SNPs in interclasses between male group and female group also(p＞0.05)However,there were significant difference distribution of rs6311 in three genotype interclasses between 117 healthy controls and 91 patients with bipolar mood disorders.TT frequency is significantly higher in patients than in controls,but GG frequency is lower(x~2= 11.031,p=0.004),and there were no significant difference of genotype frequencies in other gene locuses between two groups(p＞0.05). T allele frequency of bipolar mood disorder group was lower,but C allele frequency was higher than control group(OR=1.735,95%CI = 1.168-2.578;x~2=7.504,p =0.006).There were no significant difference of other SNPs between two groups(p＞0.05)
4.Association analysis between SNPs genotypes and mood disorders:The relative risk of rs6311 CC genotype was(OR=1.487, 95%CI=0.983～2.249,x~2=3.561,p=0.059),and that of TT was(OR =1.659,95%CI=1.216～2.262;x~2=10.287,p=0.001).The genotype frequencies of rs5443 TT、rs 5443 TC、rs 2230739 AA、rs 2230739GA and rs 1549870 GG is trendily higher in patients.However,there were no significant difference(p＞0.05).Regression analysis was performed to inVestigate the effects of the four SNPs genotypes on mood disorders.We found that TT and TC of rs 6311 entered equations,and their regression coefficient were -0.618 and -0.161 respectively.
5.The sick combination risk of RS6311 with other SNPs genetype
When TT of rs6311 combined with CC of rs5443 or CC of rs6311, the sick risk would be increased,especially CC of rs6311 with TT or CC of rs5443[(OR=4.838,95%CI=1.091～21.450;x~2=5.237,p=0.022) or(OR=3.329,95%CI= 1.703～6.510;x~2=13.662,p=0.000)];When CC of rs63 combined with GG of rs 2230739,the sick risk would be increased(OR=3.375,95%CI=0.961～11.851,x~2=4.046,p=0.044); When CT of rs6311 combined with AG of rs1549870,the sick risk was increased(OR=1.645,95%CI=1.107～2.444,x~2=6.313,p=0.013),too.
Conclusions:
1.The SNP of rs6311,located in 5-HT2A,associates with the mood disorders in Chinese Han.It also has the association with the depressive disorder and the bipolar affective disorder.The gene mutation of rs6311 would lead to mood disorder directly perhaps or there were virulence gene near the genetic locus possibly.We could reach the conclusion that the CC genotype carrier suffer from higher risk of the onset of the disorders,while T allele carrier lower risk.On the other hand,since there is no evidence that the rs6311 affects the expression of the 5-HT_(2A)gene, the results on rs 6311 might suggest that there is another functional locus near it.Therefore,it is worthy to undergo the detail investigation.
2.Both rs 5443 in GNB3 and rs 2230739 in ADCY9 are high allelic frequency SNPs in Chinese Han.When CC of rs6311 combined with Tr or CC and with GG of rs 2230739,the sick risk is increased obviously, although there is no evidence for association between them and mood disorders.The two SNPs allele located at coding region,so GNβ3 and ADCY9 may be the minor genes on mood disorders.
3.No proofs were found that there were association between PDE1Ars1549870 and mood disorders.
4.No polymorphism of rs 2551638 in CREB1 among Chinese Han was found,so we can not infer whether CREB is related to mood disorders.
PARTⅡAssociation between Polymorphisms of the Genes Related to 5-HT_(2A)Pathway and Phenotypes of Major Depression Disorder
Objective:
To investigate the relationship between four SNPs located in the genes related to 5-HT_(2A)pathways and symptoms of major depression disorder(MDD)and the association of the SNPs with MDD.
Methods:
A total of 194 patients with major depression disorder(MDD)were recruited in this study.According to DSM-Ⅳand CCMD-Ⅲcriteria,the symptoms,episode of tendency,and psychotic symptoms were scaled.
Among 194 patients with MDD,the SSRIs treated outcome was evaluated in an open-trail study.174 out of them were followed up longer than one year while the optimal scaling was used to investigate the association between different genotypes of the SNPs and phenotypes, such as the symptoms and the outcome with SSRIs treatment.
Results:
1.Relationship between four SNPs and fundamental symptoms
The Multiple Correspondence Analysis shows the strong association between the four SNPs and the symptoms of MDD.The genotypes of rs6311CC,rs5443CC,and rs1549870GG are relatively closed to the symptom 2 in the same block.The distance from rs5443CC and rs1549870GG to the symptom 2 is the shortest.The genotypes of rs5443CT,rs1549870AG and rs2230739AG are in the same zone. Although the distances between the three SNPs are short,no association between them and the fundamental symptoms of MDD or suspected depressive mood was found.
2.Relationship between four SNPs and accessory symptoms
The Multiple Correspondence Analysis also shows the association between the four SNPs and the accessory symptoms.The genotype of rs6311CC and accessory symptoms 7(suicidal thoughts and acts)are in the same zone,because the distance between them is the shortest. However,the genotype rs6311TT and the non-suicide are in the same block and stay very close.The distance between rs6311CC and symptoms, including insomnia and cognitive symptoms,is relative short.The rs5443CT and the rs1549870AG associate with fatigue symptoms.
3.Relationship between four SNPs and other clinical characters
The Multiple Correspondence Analysis shows the association between the four SNPs and other clinical characters.The rs6311CC and depressive episode with psychotic symptoms and relapse are in the same block.The genotype rs6311Tr predicts less relapses of MDD because both of them are in the same block.The rs1549870GG and depression without psychotic symptoms are in the same zone and near.
4.Relationship between the four SNPs and the long-term outcome with SSRIs treatment.
Two SNPs of rs5443 and rs2230739 associated with short-term outcome with SSRIs treatment.The coefficients of regression are 0.181 and 0.283,respectively.
The rs2230739GG predicts the good long-term outcome with SSRIs treatment.The coefficient of regression is 0.400.
Conclusion:
1.The rs6311CC strong associates with depressive symptoms, including loss of interest and pleasurable feeling,suicide,insomnia, psychotic symptoms and relapse tendency.It suggests that rs6311 may be a functional SNP affecting the expression of the 5-HT_(2A)gene.It remains unclear whether the polymorphism of rs6311 is the genotype of depression or not.
2.The rs5443TT(Gβ_3)and rs2230739GG(ACDY_9)carriers have better short-term response to SSRIs.It is presumed that different genotypes of rs5443(Gβ_3)and rs223073(ADCY_9)can modulate the second message signal conduction pathways,and therefore lead to different response.
3.The rs2230739GG(ADCY_9)carriers have better long-term respponse to SSRIs.We may conclude the polymorphism of rs2230739 (ADCY_9)may be the biological basis for the inter-individual different response.
目的:
探讨5-HT_(2A)相关转导通路上G蛋白、腺苷酸环化酶、磷酸二酯酶和cAMP反应元件结合蛋白(CREB)相关基因SNPs与心境障碍关系,分析相关基因突变合并存在时是否增加心境障碍发病风险。
方法:
1.根据美国精神障碍诊断与统计手册第四版(DSM-Ⅳ)和《中国精神障碍分类方案及诊断标准(第三版)》(CCMD-3)有关心境障碍的诊断标准,选择符合有关双相或抑郁症诊断标准的汉族患者417例(其中抑郁症326例,双相障碍91例),在相同地区范围内选择293名汉族健康对照;分别比较病例组基因型、等位基因分布差异,并与心境障碍进行关联分析。
2.采用连接酶反应技术(LDR),检测5-HT_(2A)rs6311、GNB3rs5443、ADCY9rs2230739和PDE_(1A)rs1549870等5-HT_(2A)相关信号转导的5个SNPs的基因多态性。
3.选用SPSS 11.5 for windows软件包进行数据处理。采用拟合优度卡方检验,分析基因型、等位基因频率是否符合Hardy-Weinderg平衡定律;病例和对照组的基因型和等位基因频度比较,比较采用X_2检验;选用多元回归分析、关联比(odds ratio,OR)和95%的置信区间(confidence in teval,CI)评价患病风险;显著性水平为p=0.05。
结果:
1.5个SNPs位点的检测结果:对710个汉族人DNA样本的rs6311、rs5443、rs2230739、rs 2551638和rs1549870等5个SNPs位点的检测发现,rs6311、rs5443、rs2230739和rs1549870在汉族人群中存在多态性,而CREB1rs2551638则在汉族人中不存在多态性。
2.病例组与对照组SNPs基因型频率和等位基因频率比较:417例心境障碍患者rs6311的TT、TC和CC三种基因型频率分别为0.316、0.494和0.19,其T等位基因频率为0.563,C等位基因频率为0.437;293名健康对照rs6311的TT、TC和CC三种基因型频率为0.433、0.430和0.137,其T等位基因频率为0.648,C等位基因频率为0.352;三种基因型分布存在显著性差异,病例组TI型明显减少,而CC型增多(x~2=11.003,p=0.004);病例组T等位基因频率降低,c等位基因频率增高(OR=1.434,95%CI=1.153～1.783;x~2=10.523,p=0.001)。417例心境障碍患者rs5443的TT、TC和CC三种基因型频率为0.18、0.472和0.348,其T等位基因频率为0.416,C等位基因频率为0.584;293名健康对照rs5443的TT、TC和CC三种基因型频率为0.181、0.505和0.314,其T等位基因频率为0.433,C等位基因频率为0.567;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。415例心境障碍患者rs2230739的GG、GA、AA三种基因型频率分别为0.176、0.498和0.335,其G等位基因频率为0.42,A等位基因频率为0.58;293名对照组rs2230739的GG、GA、AA三种基因型频率分别为0.119、0.515和0.365,其G等位基因频率为0.377,A等位基因频率为0.632;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。408例心境障碍患者rs1549870的GG、GA、AA三种基因型频率分别为0.49、0.426和0.083,其G等位基因频率为0.703,A等位基因频率为0.297;291名对照组rs1549870的GG、GA、AA三种基因型频率分别为0.557、0.361和0.082,其G等位基因频率为0.737,A等位基因频率为0.263;两组基因型和等位基因比较差异均无显著性意义(p＞0.05)。
3.不同亚型间SNPs基因型和等位基因分布比较:326例抑郁症患者中共有男134例,女192例,比较抑郁组与对照组比较发现,rs6311三种基因型分布存在组间显著性差异,抑郁症组TI型明显减少,而GG型增多(x~2=6.460,p=0.04),抑郁症组的T等位基因频率低于对照组,C等位基因频率则明显高于对照组(OR=1.360,95%CI 1.080～1.712;x~2=6.865,p=0.009);rs5443、rs2230739和rs1549870的基因型分布频率和等位基因频率则未见两组间存在明显差异(p＞0.05)。抑郁症组男性患者与女性患者4个SNPs基因型和等位基因分布比较,均未见明显组间差异(p＞0.05)。
91例双相障碍患者与117健康对照比较发现,rs6311三种基因型分布存在组间显著性差异,双相组TT型明显减少,而GG型增多(x~2=11.031,p=0.004、);其他位点的基因型分布频率则未见两组间存在明显差异(p＞0.05)。双相组rs6311T等位基因频率低于对照组,C等位基因频率则明显高于对照组(OR=1.735,95%CI=1.168～2.578;X~2=7.504,p=0.006);其他SNPs的两组差异未见显著性意义(p＞0.05)。
4.SNPs基因型与心境障碍的关联分析:将病例组与对照组rs6311、rs5443、rs2230739和rs1549870等4个SNPs的基因型进行关联分析发现,rs6311CC基因型患病的相对危险度为(OR=1.487,95%CI=0.983～2.249;x~2=3.561,p=0.059),TT基因型患病的相对危险度为(OR=1.659,95%CI=1.216～2.262;x~2=10.287,p=0.001)。rs5443 TF、rs5443 TC、rs2230739AA、rs2230739GA、rs1549870 GG则均未见组间差异(p＞0.05)。采用logistic回归分析,4个SNPs各基因型心境障碍关系,结果发现rs6311的TT和TC基因型进入方程,回归系数为分别为-0.618和-0.161。
5.rs6311与其他SNPs患病的联合风险:将rs6311各基因型与其他SNPs基因型的联合风险进行比较发现,rs6311的CC与rs5443TT或CC合并存在时,患病风险增加[(OR=4.838,95%CI=1.091～21.450;x~2=5.237,p=0.022)或(OR=3.329,95%CI=1.703-6.510;x~2=13.662,p=0.000)];rs6311的CC与rs2230739的GG合并时患病风险增加[(OR=3.375,95%CI=0.961～11.851,x~2=4.046,p=0.044)];rs6311 CT与rs1549870 AG合并患病风险增加[(OR=1.645,95%CI=1.107～2.444,x~2=6.313,p=0.013)]。
结论:
1.5-HT_(2A)rs6311在汉族心境障碍患者存在C等位基因频率增高,T位基因频率降低现象,且C等位基因频率增高在抑郁和双相中普遍存在,rs6311C等位基因频率升高导致患病风险增加,提示rs6311可能是5-HT_(2A)基因的高功能位点,建议将该位点作为心境障碍的标志性位点进一步研究。
2.Gβ3的rs5443和ADCY_9的rs2230739两个位点在汉族中均属高频位点,病例组与对照比较没有发现与心境障碍存在关联的证据,但当rs6311CC与rs5443TT或CC型,以及与rs2230739的GG合并存在时患病风险有明显增加趋势,提示Gβ_3和ADCY_9可能是心境障碍的微效基因之一。
3.没有发现PDE1Ars1549870与心境障碍关联的直接证据。
4.CREB1rs2551638位点在汉族患者中不存在多态性,无法依赖该位点推断CREB与心境障碍的关系。
第二部分5-HT_(2A)信号转导相关SNP_s与抑郁症表型特征的关系
目的:
探讨5-HT_(2A)信号传导通路的rs6311、rs5443、rs2230739、rs1549870等4个SNPs与抑郁症表型特征的关系,进一步论证这些SNPs与心境障碍的关系。
方法:
参照DSM-Ⅳ和CCMD-3对194例抑郁症患者临床症状,发作倾向和是否伴有精神病性症状进行分级评定,采用开放性临床治疗观察了194抑郁症患者对SSRIS的疗效,并对174例进行了为期1年以上的随访,观察其长期疗效;采用最优尺度检验分析SNPs基因型抑郁症表型特征与疗效的关系。
结果
1.四个位点与基本症状的关系:四个SNP_s基因型与基本症状的多重对应分析图显示:rs6311CC、rs5443CC与rs1549870GG与兴趣减少(基本症状2)在一个区域内,相对距离较近,其中rs5443CC与rs1549870GG距离最为接近;rs5443CT、rs1549870AG、rs2230739AG在一个区内,距离相对较近,没有发现与心境低落或可疑心境低落相关的基因型存在。
2.4个位点与附加症状的关系:4个SNPS基因型与附加症状的多重对应分析图显示:rs6311CC与自杀观念及行为在同一单位阵内,与自杀观念距离最近,rs6311TT则与无自杀者同在同一单位阵,且相距紧密;rs6311CC还与失眠症状、认识症状在一个单位阵内,rs5443CT,rs1549870AG与疲劳症状群在同一单位阵。
3.其他临床特征的关系:4个SNPS基因型与其他临床特征的多重对应分析图显示:rs6311CC与伴有精神病性症状和多次复发同在一个单位阵内,rs6311TT和少复发同在一个单位阵内;rs1549870GG与不伴精神症状同在一个单位阵内,距离较近。
4.4个位点与SSRI类疗效及长期疗效的关系:rs5443、rs2230739和SSRI疗效有关,其回归系数分别为0.181和0.283;rs2230739和长期疗效有关,其回归系数为0.400。
结论:
1.据本研究发现rs6311CC型与抑郁症的部分症状包括兴趣减少、自杀、失眠、精神病性症状和复发倾向关系密切,推测rs6311可能是5-HT_(2A)的功能位点,建议进一步探讨5-HT_(2A)rs6311T/C多态性是否属于抑郁症的生物学内表型。
2.Gβ3rs5443TT和ACDY_9rs2230739GG患者对SSRI类的短期疗效相对较好,Gβ3和ACDY_9可能是不同患者SSRIs疗效差异的分子遗传学基础。
3.ACDY_9rs2230739GG型长期抗抑郁治疗效果较好,推测ACDY_9rs2230739基因多态性可能是个体间长期疗效差异的生物学基础。
PARTⅠAssociation between the 5-HT_(2A)pathway related genes and mood disorders
Objective:
This research aims at the investigating the association between 5-HT2A pathway related genes,including G protein,adenylcyclase, phosphodiesterase or cAMP responsive element binding protein,and mood disorders.Also,the effects of the gene x gene interaction on the risk of mood disorders will be investigated.
Methods:
(1)With the case-control design,417 mood disorders and depressive disorder patients(326 depressive disorder patients,91 mood disorder patients),met the criteria of DSM-Ⅳand CCMD-3,and 293 healthy Chinese Han were recruited in Henan Province,and respectively compared distributional difference of genotype and allele between two groups,and analyzed association between SNP_s and mood disorders.
(2)Five SNPs of 5-HT2A rs6311、GNβ3rs5443、ADCY9rs2230739, PDE1Ars1549870,which were located at the genes of 5-HT_(2A)pathway, were discriminated by using the assay of LDR.
(3)Performing SPSS 11.5 package,the Hardy-Weinberg equilibrium, the distribution of the allelic and genotype frequencies among the cases and controls were analyzed by x~2 test.The morbidity risk was evaluated using 95%confidence interval,odds ratio and confidence interval.The level of significance was p=0.05.
Results:
1.The polymorphism of the five SNPs::There were polymorphism of rs6311,rs5443,rs2230739 and rs 1549870,and no polymorphism of CREB1 rs255163 among these 710 Chinese Han(417 patients with mood disorders and 293 healthy controls).
2.Comparison of genotypic/allele frequency between patients and controls:Genotypic frequencies of the wild-type homozygote(TT),TC and the mutation homozygote(CC)of rs6311 among 417 patients with mood disorders were 0.316,0.494 and 0.19 respectively,T allel frequency was 0.563,and C allel frequency was 0.437.Correspondingly in 293 healthy controls,genotypic frequencies of TT,TC and CC were 0.433, 0.430 and 0.137 respectively,T allel frequency was 0.648,and C allel frequency was 0.352.There was significant difference of genotypes distribution of rs6311 between patients and controls.The mutation homozygote(CC)frequency is significantly higher in patients than in controls,but the wild-type homozygote(TT)frequency is lower (x~2=11.003,p=0.004).Also the T allele frequency was lower and the C allelic frequency is higher in the patients(OR=1.434,95%CI=1.153～1.783;x~2=10.523,p=0.001).As for rs5443,its genotypic frequencies of TT,TC and CC in 417 patients were 0.18,0.472 and 0.348 respectively,T allel frequency was 0.416,and C allel frequency was 0.581. Correspondingly in healthy controls,its genotypic frequencies of TT, TC and CC were 0.119,0.515 and 0.365 respectively,T allel frequency was 0.433,and C allel frequency was 0.567.There were significant difference in neither genotype nor allel distribution between patients and controls(p＞0.05).Genotypic frequencies of GG,GA and AA of rs 2230739 among 415 patients with mood disorders were 0.176,0.498 and 0.335 respectively,G allel frequency was 0.563,and A allel frequency was 0.437.Correspondingly in 293 healthy controls,genotypic frequencies of GG,GA and AA of rs2230739 were 0.119,0.515 and 0.365 respectively,G allel frequency was 0.377,and A allel frequency was 0.632.There was no significant difference of genotype\allel distribution between patients and controls(p＞0.05).As for rs1549870,its genotypic frequency of GG,GA and AA among 408 patients were 0.49,0.426 and 0.083 respectively,G allel frequency was 0.703,and A allel frequency was 0.297.Correspondingly in healthy controls,its genotypic frequencies of GG,GA and AA were 0.557,0.361 and 0.082 respectively,G allel frequency was 0.737,and A allel frequency was 0.263.There were significant difference in neither genotype nor allel distribution between patients and controls(p＞0.05)
3.Comparison of genotypic and allele distribution of SNPs in different subtypes:There were significant difference in three genotype interclasses of rs6311 by comparing between control group and depressive group(326 cases,134 males,192 females).In depressive group, not only TT obviously decreased,while CC mcreased(x~2=6.460,p-0.04), but also T allele frequency of depressive group was lower,while C allele frequency was higher in depressive group(OR=1.360,95%CI=1.080～1.712;x~2= 6.865,p=0.009);There were no significant difference of genotypic \allele distribution of rs5443,rs2230739 and rs1549870 among interclasses(p＞0.05),and no significant difference genotypic\allele distribution of four SNPs in interclasses between male group and female group also(p＞0.05)However,there were significant difference distribution of rs6311 in three genotype interclasses between 117 healthy controls and 91 patients with bipolar mood disorders.TT frequency is significantly higher in patients than in controls,but GG frequency is lower(x~2= 11.031,p=0.004),and there were no significant difference of genotype frequencies in other gene locuses between two groups(p＞0.05). T allele frequency of bipolar mood disorder group was lower,but C allele frequency was higher than control group(OR=1.735,95%CI = 1.168-2.578;x~2=7.504,p =0.006).There were no significant difference of other SNPs between two groups(p＞0.05)
4.Association analysis between SNPs genotypes and mood disorders:The relative risk of rs6311 CC genotype was(OR=1.487, 95%CI=0.983～2.249,x~2=3.561,p=0.059),and that of TT was(OR =1.659,95%CI=1.216～2.262;x~2=10.287,p=0.001).The genotype frequencies of rs5443 TT、rs 5443 TC、rs 2230739 AA、rs 2230739GA and rs 1549870 GG is trendily higher in patients.However,there were no significant difference(p＞0.05).Regression analysis was performed to inVestigate the effects of the four SNPs genotypes on mood disorders.We found that TT and TC of rs 6311 entered equations,and their regression coefficient were -0.618 and -0.161 respectively.
5.The sick combination risk of RS6311 with other SNPs genetype
When TT of rs6311 combined with CC of rs5443 or CC of rs6311, the sick risk would be increased,especially CC of rs6311 with TT or CC of rs5443[(OR=4.838,95%CI=1.091～21.450;x~2=5.237,p=0.022) or(OR=3.329,95%CI= 1.703～6.510;x~2=13.662,p=0.000)];When CC of rs63 combined with GG of rs 2230739,the sick risk would be increased(OR=3.375,95%CI=0.961～11.851,x~2=4.046,p=0.044); When CT of rs6311 combined with AG of rs1549870,the sick risk was increased(OR=1.645,95%CI=1.107～2.444,x~2=6.313,p=0.013),too.
Conclusions:
1.The SNP of rs6311,located in 5-HT2A,associates with the mood disorders in Chinese Han.It also has the association with the depressive disorder and the bipolar affective disorder.The gene mutation of rs6311 would lead to mood disorder directly perhaps or there were virulence gene near the genetic locus possibly.We could reach the conclusion that the CC genotype carrier suffer from higher risk of the onset of the disorders,while T allele carrier lower risk.On the other hand,since there is no evidence that the rs6311 affects the expression of the 5-HT_(2A)gene, the results on rs 6311 might suggest that there is another functional locus near it.Therefore,it is worthy to undergo the detail investigation.
2.Both rs 5443 in GNB3 and rs 2230739 in ADCY9 are high allelic frequency SNPs in Chinese Han.When CC of rs6311 combined with Tr or CC and with GG of rs 2230739,the sick risk is increased obviously, although there is no evidence for association between them and mood disorders.The two SNPs allele located at coding region,so GNβ3 and ADCY9 may be the minor genes on mood disorders.
3.No proofs were found that there were association between PDE1Ars1549870 and mood disorders.
4.No polymorphism of rs 2551638 in CREB1 among Chinese Han was found,so we can not infer whether CREB is related to mood disorders.
PARTⅡAssociation between Polymorphisms of the Genes Related to 5-HT_(2A)Pathway and Phenotypes of Major Depression Disorder
Objective:
To investigate the relationship between four SNPs located in the genes related to 5-HT_(2A)pathways and symptoms of major depression disorder(MDD)and the association of the SNPs with MDD.
Methods:
A total of 194 patients with major depression disorder(MDD)were recruited in this study.According to DSM-Ⅳand CCMD-Ⅲcriteria,the symptoms,episode of tendency,and psychotic symptoms were scaled.
Among 194 patients with MDD,the SSRIs treated outcome was evaluated in an open-trail study.174 out of them were followed up longer than one year while the optimal scaling was used to investigate the association between different genotypes of the SNPs and phenotypes, such as the symptoms and the outcome with SSRIs treatment.
Results:
1.Relationship between four SNPs and fundamental symptoms
The Multiple Correspondence Analysis shows the strong association between the four SNPs and the symptoms of MDD.The genotypes of rs6311CC,rs5443CC,and rs1549870GG are relatively closed to the symptom 2 in the same block.The distance from rs5443CC and rs1549870GG to the symptom 2 is the shortest.The genotypes of rs5443CT,rs1549870AG and rs2230739AG are in the same zone. Although the distances between the three SNPs are short,no association between them and the fundamental symptoms of MDD or suspected depressive mood was found.
2.Relationship between four SNPs and accessory symptoms
The Multiple Correspondence Analysis also shows the association between the four SNPs and the accessory symptoms.The genotype of rs6311CC and accessory symptoms 7(suicidal thoughts and acts)are in the same zone,because the distance between them is the shortest. However,the genotype rs6311TT and the non-suicide are in the same block and stay very close.The distance between rs6311CC and symptoms, including insomnia and cognitive symptoms,is relative short.The rs5443CT and the rs1549870AG associate with fatigue symptoms.
3.Relationship between four SNPs and other clinical characters
The Multiple Correspondence Analysis shows the association between the four SNPs and other clinical characters.The rs6311CC and depressive episode with psychotic symptoms and relapse are in the same block.The genotype rs6311Tr predicts less relapses of MDD because both of them are in the same block.The rs1549870GG and depression without psychotic symptoms are in the same zone and near.
4.Relationship between the four SNPs and the long-term outcome with SSRIs treatment.
Two SNPs of rs5443 and rs2230739 associated with short-term outcome with SSRIs treatment.The coefficients of regression are 0.181 and 0.283,respectively.
The rs2230739GG predicts the good long-term outcome with SSRIs treatment.The coefficient of regression is 0.400.
Conclusion:
1.The rs6311CC strong associates with depressive symptoms, including loss of interest and pleasurable feeling,suicide,insomnia, psychotic symptoms and relapse tendency.It suggests that rs6311 may be a functional SNP affecting the expression of the 5-HT_(2A)gene.It remains unclear whether the polymorphism of rs6311 is the genotype of depression or not.
2.The rs5443TT(Gβ_3)and rs2230739GG(ACDY_9)carriers have better short-term response to SSRIs.It is presumed that different genotypes of rs5443(Gβ_3)and rs223073(ADCY_9)can modulate the second message signal conduction pathways,and therefore lead to different response.
3.The rs2230739GG(ADCY_9)carriers have better long-term respponse to SSRIs.We may conclude the polymorphism of rs2230739 (ADCY_9)may be the biological basis for the inter-individual different response.
引文
[1]Gelder MG,Lopezlbor Jr,Andreasen NC,et al.The new oxford textbook of psychiatry Oxford.Oxford University Press,2000.
[2]贾福军,胡宪章.精神医学与神经病学.郑州:河南医科大学出版社,2000.
[3]郝伟.精神病学.第四版,北京:人民卫生出版社,2002,107-109.
[4]Neumeister A.Tryptophan depletion,Serotonin,and depression:where do we stand?.psychopharmacol Bull,2003,37(4):99-115.
[5]王雪琦,路长林,李丽云等.大鼠抑郁模型的脑磁共振成像研究.中华精神科杂志,1999,32(1):12-14.
[6]Blier E Pharmacology of Rapid-Onset Antidepressant Treatment Strategieso.J Clin Psychiatry.2001,62 Suppl 15:12-17.
[7].Fricker AD,Rios C.Serotonin receptor activation leads to neurite outgrowth and neuronal survival.Brain Res Mol Brain Res.2005,18,138(2):228-235.
[8]Slotkin TA,Cousins MM,Serotonergic cell signaling in an animal model of aging and depression:olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats.Neuropsychopharmacology.2005,30(1):52-57.
[9]Lahshmi N,Yutham,Peter F,et al.Brain Serotonin Receptors in Major Depression A Positron Emission Tomography Study.Arch Gert Psychiatly,2000,57:850-858.
[10]江开达.精神药理学,第一版,北京:人民卫生出版社,2007.
[11]姚树桥.医学心理学与精神病学,第二版,北京:人民卫生出版社,2007。
[12]Chen Z,Skolnick P.Triple uptake inhibitors:therapeutic potential in depression and beyond.Expert Opin Investig Drugs.2007,16(9):1365-1377.
[13]龚绍麟.抑郁症.第一版,北京:人民卫生出版社,2003.
[14]Cheng Z,Sheldrick EL,Marshall E,et al.Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid.Reproduction,2007,133(5):1017-1026.
[15]金光亮,周东丰,郭霞珍,等.慢性利血平抑郁模型大鼠脑内游离钙离子、
钙调素和环核苷酸含量的变化.中华精神科杂志,1997,30(5):67-69.
[16]许绍芬主编.神经生物学.第二版,上海:上海科技出版社,2003.
[17]Schreiber G,Avissar S.G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders.Isr Med Assoc J,2000,2Suppl:86-91.
[18]Avissar S,Nechamkin Y.Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression.Am J Psychiatry,1997,154(2):211-217.
[19]Young LT,Li PP,Kish SJ,et.al.Cerebral Hex Gs alpha preteiilevels and forskolin-stimulated cyclic AMP formation are ilwrcasedin bipolar affective disorder.J Neurochem,1993,61(3 1):890-898.
[20]Young LT,Li PP,Kamble A,et al.Lack of effect of antidepressants on mononuclear leukocyte G-protein level or function in depressed outpatients.Affect Disord,1996,39(3):201-207.
[21]Menninger JA,Tabakoff B.Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with majo rdepression.Biol Psychiatry,1997,42(1):30-38.
[22]Montezinho LP,MΦrk A,Duarte CB,et al.Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.Bipolar Disord,2007,9(3):290-297.
[23]Matowe WC,Ananthalakshmi KV,Kombian SB,et al.Role of protein kinase C in substance P-induced synaptic depression in the nucleus accumbens in vitro.Med Princ Pract.,2007,16(2):90-99.
[24]Gould TD,Manji HK.Signaling networks in the pathophysiology and treatment of mood disorders.Psychosom Res,2002,53(2):687-697.
[25]Hines LM,Tabakoff B.WHO/ISBR A Study on State and Trait Markers of Alcohol Use and Dependence Investigators Platelet adenylyl cyclase activity:a biological marker for major depression and recent drug use.BiolPsychiatry,2005,58(12):955-962.
[26] Newman ME, Lerer B, Lichtenberg P, et al. Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology, 1992,109(2): 231-234.
[27] Mooney JJ, Samson JA, McHale NL, et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals.Biol Psychiatry, 1998, 43(8): 574-583.
[28] Boer U, Cierny I, Krause D, Heinrich A, et al..Chronic Lithium Salt Treatment Reduces CRE/CREB-Directed Gene Transcription and Reverses Its Upregulation by Chronic Psychosocial Stress in Transgenic Reporter Gene Mice. Neuropsychopharmacology, 2007 Nov 28.
[29] Nibuya M, Ncstler EJ, Duman RS, et al.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB) in rat hippocampus. J Neurosci, 1996,16 : 2365-2372.
[30] Levinson DF.The genetics of depression: a review. Biol Psychiatry, 2006, 60(2): 84-92.
[31] Laje G, Paddock S, Manji H, et al.Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry, 2007,164(10): 1530-1538.
[32] Harvey M, Belleau P, Barden N, et al.Gene interactions in depression: pathways out of darkness.Trends Genet, 2007, 23(11): 547-556.
[33] Hayden EP, Nurnberger JI Jr. Molecular genetics of bipolar disorder.Genes Brain Behav. 2006,5(1): 85-95.
[34] Lee HJ, Cha JH, Ham BJ, et al. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics, 2004,4(1): 29-33.
[35] Johansson C, Willeit M, Aron L, et al.Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism. Biol Psychiatry, 2004, 55(3): 317-319.
[36] Millar JK, Pickard BS, Mackie S, et al. DISCI and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP Signaling.Science,2005,310(5751):1187-1191.
[37]Hines LM,Hoffman PL,Bhave S,et al.A sex-specific role of type Ⅶ adenylyl cyclase in depression.J Neurosci,2006,26(48):12609-12619.
[38]Hellevuo K,Welbom R,Menninger JA,et al.Human adenylyl cyclase type 7contains polymorphic repeats in the 3' untranslated region:investigations of association with alcoholism.Am J Med Genet,1997,74(1):95-98.
[39]Zubenko GS,Hughes HB 3rd,Stiffler JS,et al Sequence variations in CREB1cosegregate with depressive disorders in women.Mol Psychiatry,2003,8(6):611-618.
[40]刘晓华.抑郁症遗传模式及其与CREBl_BDNF 基因的关联和表达研究.优秀博士论文数据库,2006.
[41]Ogden CA,Rich ME,Schork NJ,et al.Candidate genes,pathways and mechanisms for bipolar(manic-depressive)and related disorders:an expanded convergent functional genomics approach.Mol Psychiatry,2004,9(11):1007-1029.
[42]陈彦方.中国精神疾病诊断与分类标准(第三版).济南:山东科学出版社,2001,83-91.
[43]庞天鉴译.美国精神科学会DSM-IV分类与诊断标准.2001,130-160.
[44]张明园.精神科评定量表手册.长沙:湖南科学技术出版社,1993,81-127.
[45]冯作化主编.医学分子生物学.第一版,北京:人民卫生出版社,2003,184-197
[46]Cargill M,Altshuler D,Ierland J,et al.Characterization of single-nucleotide polymorphisms in coding regions of human genes.Nature Genet,1999,22(3):231-238.
[47]Lander ES.The new genomics:global views of biology.J Science,1996,274(5887):536-539.
[48]耿茜,蒋伟莹.人类基因组单体型图计划及其意义.国外医学遗传学分册,2005,28(1):1-5.
[49]http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6311.
[50]Stein DJ,Hemmings S,Moolman-Srnook H,et al.5-HT2A:its role in frontally mediated executive function and related psychopathology.CNS Spectr,2007,12(7):512-516.
[51]Arias B,Gasto C,Catalan R,et al.The 5-HT(2A)receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients.Am J Med Genet,2001,105(8):801-804.
[52]Rosel P,Arranz B,Urretavizcaya M,et al.Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suidde victims.Neumpsychobiology,2004,49(4):189-195.
[53]Arranz MJ,Erdmann J,Kirov G,et al.5-HT2A receptor and bipolar affective disorder:association studies in affected patients.Neurosci Lett,1997,224(2):95-98.
[54]Warrington L,Lombardo I,Loebel A,et al.Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.CNS Drugs,2007,21(10):835-849.
[55]Enoch MA,Goldman D,Barnett R,et al.Association between seasonal affective disorder and the 5-HT2A promoter polymorphism1438G/A.Mol Psychiatry,1999,4(1):89-92.
[56]Du L,Bakish D,Lapierre YD,et al.Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder.Am J Med Genet,2000,96(1):56-60.
[57]Sher L.Possible genetic link between eating disorders and seasonal changes in mood and behavior.Med Hypotheses,2001,57(5):606-608.
[58]Fukuda Y,Koga M,Arai M,et al.Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes.Biol Psychiatry,2006,60(12):1331-1335.
[59]Bondy B,Buettner A,Zill P.Genetics of suicide.Mol sychiatry,2006,11(4):336-351.
[60]Jokela M,Keltikangas-Jarvinen L,et al.Serotonin receptor 2A gene and the,influence of childhood maternal nurturance on adulthood depressive symptoms.Arch Gen Psychiatry,2007,64(3):356-360.
[61]Serretti A,Calati R,Giegling I,et al.5-HT2A SNPs and the Temperament and Character Inventory.Prog Neuropsychopharrnacol Biol Psychiatry,2007,31(6):1275-1281.
[62]De Luca V,Likhodi O,Kennedy JL,et al.Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism:analysis of suicidality in schizophrenia and bipolar disorder.Am J Med Genet B Neuropsychiatr Genet,2007,144(3):370-374.
[63]Giegling I,Hartmann AM,M611er HJ,et aI.Anger-and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene.J Affect Disord.,2006,96(1-2):75-81.
[64]胡健,胡友梅.G蛋白亚单位基因家族研究进展.生理科学进展,2003,34(2):131-135.
[65]Zill P,Baghai TC,Zwanzger P,et al.Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment.Neuroreport,2000,11(9):1893-1897.
[66]Lin CN,Tsai S J,Hong CJ.Association analysis of a functional G protein beta3subunit gene polymorphism(C825T)in mood disorders.Neuropsychobiology,2001,44(3):118-121.
[67]Kunugi H,Kato T,Fukuda R,et al.Association study of C825T polymorphism of the G-protein 133 subunit gene with schizophrenia and mood disorders.J Neural Transm,2002,109(2):213-218.
[68]肖红,姚辉,郭素婉,等.G蛋白β3亚基基因C825T多态性与抑郁症及SSRI和SNRI类抗抑郁药的关系.中国临床药理学杂志,2002,18(6):414-416.
[69]Willeit M,Praschak-Rieder N,Zill P,et al.C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder.Biol Psychiatry,2003,54(7):682-686.
[70]Vargens DD,Almendra L,Struchiner CJ,et al.Distribution of the GNB3825C＞Tpolymorphism among Brazilians:impact of population structure.Eur J Clin Pharmacol,2008,64(3):253-256.
[71]Sami Anttila,Olli Kampman,Ari Illi,et al.Association between 5-HT2A,TPH1 and GNB3 genotypes and response to typical neuroleptics:a serotonergic approach.BMC Psychiatry,2007,7(1):22-28.
[72]鞠躬,吕国蔚,王百忍.神经生物学.第一版,北京:人民卫生出版社,2004:159-176.
[73]Cowburn RF,Marcusson JO,Eriksson A,et al.Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims.Brain Res,1994,633(1-2):297-304.
[74]Mizrahi C,Stojanovic A,Urbina M,et al.Differential cAMP levels and serotonin effects in blood peripheral mononuclear cells and lymphocytes from major depression patients.Int Immunopharmacol,2004,4(8):1125-1133.
[75]Toyota T,Hattori E,Meerabux J,et al.Molecular analysis,mutation screening,and association study of adenylate cyclase type 9 gene(ADCY9)in mood disorders.Am J Med Genet,2002,14(1):84-92.
[76]Gros R,Van Uum S,Hutchinson-Jaffe A,et al.Increased enzyme activity and beta-adrenergic mediated vasodilation in subjects expressing a single-nucleotide variant of human adenylyl cyclase 6.Arterioscler Thromb Vasc Biol.2007,27(12):2657-63.
[77]Hacker BM,Tomlinson JE,Wayman GA,et al.Cloning,chromosomal mapping,and regulatory properties of the human type 9 adenylyl cyclase(ADCY9).Genomics,1998,50(1):97-104.
[78]Cumbay MG,Watts VJ.Novel regulatory properties of human type 9 adenylate cyclase.J Pharmacol Exp Ther,2004,310(1):108-115.
[79]Ewald H,Mors O,Flint T,et al.A possible locus for manic depressive illness on chromosome 16p13.Psychiatr Genet,1995,5(2):71-81.
[80]Mclnnes LA,Escamilla MA,et al.A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees.Proc Natl Acad Sci U S A,1996,93(23):13060-13065.
[81]Toyota T,Yamada K,Saito K,et al.Association analysis of adenylate cyclase type 9 gene using pedigree disequilibrium test in bipolar disorder.Mol Psychiatry,2002,7(5):450-452.
[82]Lefievre L,de Lamirande E,Gagnon C.Presence of Cyclic nucleotide phosphodiesterases PDEiA,existing as a stable complex with calmodulin,and PDE3A in human spermatozoa.Biol Reprod,2002,67(2):423-430.
[83]田慧,张奇,朱景申.新的磷酸二酯酶及其功能.中国临床药理学杂志,2003,19(6):458-460.
[84]Nagel DJ,Aizawa T,Jeon KI,et al.Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.Circ Res,2006,98(6):777-784.
[85]Perlis RH,Purcell S,Fava M,et al.Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR~*D study.Arch Gen Psychiatry,2007,64(6):689-697.
[86]张亚林主编.高级精神学.第一版,长沙:中南大学出版社,2007,377-415.
[87]喻东山.五羟色胺和精神药理.国外医学精神病学分册,2002,29(1):41-44.
[88]Itoh T,Tokumura M,Abe K.Effects of rolipram,a phosphodiesterase 4 inhibitor,in combination with imipramine on depressive behavior,CRE-binding activity and BDNF level in learned helplessness rats.Eur J Pharmacol,2004,498(1-3):135-142.
[89]Renau TE.The potential of phosphodiesterase 4 inhibitors for the treatment of depression:opportunities and challenges.Curr Opin Investig Drugs,2004,5(1):34-39.
[90]Kakkar R,Raju RV,Sharma RK.Calmodulin-dependent cyclic nucleotide phosphodiesterase(PDE1).Cell Mol Life Sci,1999,55(8-9):1164-1186.
[91]Michibata H,Yanaka N,Kanoh Y,et al.Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A:novel splice variants,their specific expression,genomic organization,and chromosomal localization.Biochim Biophys Acta,2001,1517(2):278-287.
[92]Wong ML,Whelan F,Deloukas P,et al.Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.Proc Natl Acad Sci U S A,2006,103(41):15124-15129.
[93]Teranishi KS,Slager SL,Garriock H,et al.Variants in PDEllA and PDE1A are not associated with citalopram response.Mol Psychiatry,2007,12(12):1061-1063.
[94]Saeki K,Yuo A.Distinct involvement of cAMP-response element-dependent t ranscriptions in functional and morphological mat uration during retinoid-mediated human myeloid differentiation.Journal of Leukocyte Biology,2003,73(5):673-681.
[95]Studzinski GP,Harrison LE.Differentiation-related changes in the cell cycle traverse.Int Revc yetol,1999,189:1-58.
[96]李璞主编.医学遗传学.第二版,北京:中国协和医科大学出版社,2006,419-437。
[97]Chen A-H,Shirayama Y,Shin K-H,et al.Expression of the cAMP response element binding protein(CREB)in hippocampus produces antidepressant effect.Biol Psychiatry,2001,49:753-762.
[98]Dowlatshahi D,MacQueen GM,Wang JF,et aI.Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.Lancet,1998,352:1754-1755.
[99]Duman R,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders.Biol Psychiatry,2000,480:732-739.
[100]Rossby S,Manier DH,Liang S,et al.Venlafaxine pharmacological actions beyond aminergic receptors.Int J Neuropsychopharmacol,1999,2(1):1-8.
[101]Manier D,Shelton RC,Sulser E Noradrenergic antidepressants:does chronic treatment increase or decrease nuclear CREB-P? J Neural Transm,2002,109(1):91-99.
[102]Pliakas A,Carlson RR,Neve RL,et al.Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens.J Neurosci,2001,21(18):7397-7403.
[103]Conti A,Cryan JF,Dalvi A,et al.cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription,but not the behavioral or endocrine responses to antidepressant drugs.J Neurosci ,2002,22(8) :3262-3268.
[104] Laifenfeld D, Karry R, Grauer E, et al. Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity.Neurobiol Dis, 2005 ,20(2):432-441.
[105] Reagan LP,Hendry RM,Reznikov LR,et al.Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol, 2007,565(1-3):68-75.
[106] Thome J, Sakai N, Shin KH, et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci , 2000, 20(11): 4030-4036.
[107] Blom J, Tascedda F, Carra S, et al. Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. Neuropsychopharmacology, 2002, 26(5): 605-614.
[108] Shieh PB, Hu SC, Bobb K, et al. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron,1998,20(4):727-740.
[109] Tao X, Finkbeiner S, Arnold DB, et al. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron,1998,20:709-726.
[110] Nestler E,Aghajanian GK. Molecular and cellular basis of addiction. Science,1997, 278(5335):58-63.
[111] Milner B, Squire LR, Kandel ER, et al. Cognitive neuroscience and the study of memory. Neuron,1998,20(3):445-468.
[112] Silva A,Kogan JH,Frankland PW, et al. CREB and memory. Annu Rev Neurosci 1998,21:127-148.
[113] Zubenko GS,Hughes HB 3rd ,Maher BS, et al. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet,2002,114(8):980 -987.
[114]Zubenko GS,Maher B,Hughes HB 3rd,et al.Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent,early-onset,major depression.Am J Med Genet B Neuropsychiatr Genet,2003,123(1):1-18.
[115]Burcescu I,Wigg K,King N,Vetro A,et al.Association study of CREB1 and childhood-onset mood disorders.Am J Med Genet B Neuropsychiatr Genet,2005,137(1):45-50.
[116]Zubenko GS,Hughes HB 3rd.Effects of the G(-656)A variant on CREB1promoter activity in a glial cell line:Interactions with gonadal steroids and stress.Am J Med Genet B Neuropsychiatr Genet,2008 Jan 22.
[117]Oelke M,Hedlund P,Albrecht K,et al.Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3,4,and 5 in the human clitoris:immunohistochemical and molecular biology study.Urology,2006,67(5):1111-1116.
[118]Lippmann M,Bress A,Nemeroff CB,et al.Long-term behavioural and molecular alterations associated with maternal separation in rats.Eur J Neurosci,2007,25(10):3091.
[119]Blendy JA.The Role of CREB in Depression and Antidepressant Treatment.Biological Psychiatry,2006,59(12):1144-1150.
[120]Perlis RH,Purcell S,Fagerness J,et al.Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.Biol Psychiatry,2007,62(5):536-540.
[121]Gass P,Riva MA.CREB,neurogenesis and depression.Bioessays,2007,29(10):7-961.
[122]Young LT,Bezchlibnyk YB,Chen B,Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders:effects of diagnosis,suicide,and drug treatment.Biol Psychiatry,2004,55(6):570-577.
[123]潘阳,叶菜英,张德昌.G蛋白异二聚体与跨膜信号转导的保真.国外医学 分子生物学分册,2003,25(5):279-281.
[124]Mamdani F,Alda M,Grof P,et al.Lithium response and genetic variation in the CREB family of genes.Am J Med Genet B Neuropsychiatr Genet,2008 Jan 11.
[125]Kato T.Molecular genetics of bipolar disorder and depression.Psychiatry Clin Neurosci,2007,61(1):3-19.
[126]Blackwood DH,Pickard BJ,Thomson PA,et al.Are some genetic risk factors common to schizophrenia,bipolar disorder and depression? Evidence from DISC1,GRIK4 and NRG1.Neurotox Res,2007,11(1):73-83.
[127]Ueno S,Iga J,Numata S,So K,et al.Genetic aspects of depressive disorder.Seishin Shinkeigaku Zasshi,2007,109(9):859-863.
[128]张文彤主编.SPSS11统计分析教程.北京:北京希望电子出版社,2002,124-210.
[129]Demyttenaere K,De Fruyt J,Stahl SM.The many faces of fatigue in major depressive disorder.Int J Neuropsychopharmacol,2005,8(1):93-105.
[130]Tylee A,Gastpar M,Lepine JP,et al.Identification of depressed patient types in the community and their treatment needs:findings from the DEPRES Ⅱ(Depression Research in European Society II)survey.DEPRES Steering Committee.Int Clin Psychopharmacol,1999,14(3):153-165.
[131]Dickel,J.Veenstra-VanderWeele,N.Bivens,X.et al.Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.Biol Psychiatry,2007,61(3):322-329.
[132]Unschuld PG,Ising M,Erhardt A,et al.Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder.Am J Med Genet B Neuropsychiatr Genet,2007,144(4):424-429.
[133]Wasserman D,Geijer T,Sokolowski M,et aL Nature and nurture in suicidal behavior,the role of genetics:some novel findings conceming personality traits and neural conduction.Physiol Behav,2007,92(1-2):245-249.
[134]Goldstein TR,Bridge JA,Brent DA.Sleep disturbance preceding completed suicide in adolescents.J Consult Clin Psychol,2008,76(1):84-91.
[135]Alloy LB,Abramson LY,Whitehouse WG,et al.Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression..J Abnorm Psychol,2006,115(1):145-156.
[136]Chellappa SL,Aratijo JF.Sleep disorders and suicidal ideation in patients with depressive disorder.Psychiatry Res,2007,153(2):131-136.
[137]Liu X,Buysse DJ.Sleep and youth suicidal behavior:a neglected field.Curr Opin Psychiatry,2006,19(3):288-293.
[138]Bernert RA,Joiner TE Jr,Cukrowicz KC,et aI.Suicidality and sleep disturbances.Sleep,2005,28(9):1039-1040.
[139]Bagby RM,Psych C,Quilty LC,et al.Personality and depression.Can J Psychiatry,2008,53(1):14-25.
[140]Samochowiec J,Fiszer-Piosik E,Kucharska-Mazur J,et al.The influence of genes on the development of personality.Psychiatr Pol,2000,34(1):99-109.
[141]Ham BJ,Kim YH,Choi MJ,et al.Serotonergic genes and personality traits in the Korean population.Neurosci Lett,2004,354(1):2-5.
[142]Soloff PH,Price JC,Meltzer CC,et al.5HT2A receptor binding is increased in borderline personality disorder.Biol Psychiatry,2007,62(6):580-587.
[143]Chang HJ,Yang CY,Lin CR,et al.Determinants of suicidal ideation in taiwanese urban adolescents.J Formos Med Assoc,2008,107(2):156-164.
[144]Chang HJ,Lin MF,Lin KC.The mediating and moderating roles of the cognitive triad on adolescent suicidal ideation.Nurs Res,2007,56(4):252-259.
[145]Demyttenaere K,Adelin A,Patrick M,et al.Six-month compliance with antidepressant medication in the treatment of major depressive disorder.Int Clin Psychopharmacol,2008,23(1):36-42.
[146]梅玲玲,蒋锋,王传跃.重性抑郁症的内表型及其进展.国际精神病学杂志,2006,33(1):35-36.
[147]Wilkie MJ,Smith D,Reid IC,et al.A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.Pharmacogenet Genomics,2007,17(3):207-215.
[148]Crossley NA,Bauer M.Acceleration and augmentation of antidepressants with lithium for depressive disorders:two meta-analyses of randomized,placebo-controlled trials.J Clin Psychiatry,2007,68(6):935-940.
[149]Guzzetta F,Tondo L,Centorrino F,et al.Lithium treatment reduces suicide risk in recurrent major depressive disorder.J Clin Psychiatry,2007,68(3):380-383.
[150]刘景生主编.细胞信息与调空.第二版,北京:中国协和大学出版社,2004,235-338.
[151]Iwatsubo K,Okumura S,Ishikawa Y.Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling.Endocr Metab Immune Disord Drug Targets,2006,6(3):239-247.
[152]Gros R,Ding Q,Cao H,et al.Feldman RD Identification of a dysfunctional missense single nucleotide variant of human adenylyl cyclase Ⅵ.Clin Pharmacol Ther,2005,77(4):271-278.
[1]王学铭.精神与精神疾病的生物化学.第一版,北京:人民卫生出版社,2002,160-167.
[2]李东亮,张朝.基础神经生物学.第一版,北京:人民军医出版社,2007,113-115.
[3]姚泰.生理学.第一版,北京:人民卫生出版社,2005,410-410.
[4]Greenshaw A J,Silverstone PH.The non-antiemetic uses of serotonin 5-HT3receptor antagonists.Clinical pharmacology and therapeutic applications.Drugs,1997,53(1):20-39.
[5]Russo S,Kema IP,Fokkema MR,et al.Tryptophan as a link between psychopathology and somatic states.Psychosom Med,2003,65(4):665-671.
[6]Fink KB,G6thert M.5-HT receptor regulation of neurotransmitter release.Pharmacol Rev.2007,59(4):360-417.
[7]Fricker AD,Rios C,Devi LA,et al.Serotonin receptor activation leads to neurite outgrowth and neuronal survival.Brain Res Mol Brain Res.2005,138(2):228-235.
[8]Katona CL,Abou-Saleh MT,Harrison DA,et a/.Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.British of Psychiatry,1995,166(1):80-86.
[9]沈渔村.精神病学.第四版,北京:人民卫生出版社,2002,23-28.
[10]Brown GL,Linnoila MI.CSF serotonin metabolite(5-hIAA)studies in depression,impulsivity,and violence.Clin Psychiatry.1990,51 Suppl:31-41
[11]刘协和,袁德基.牛津精神病学教科书(中文版).第一版,四川:四川大学出版社,2004,287-296.
[12]Nemeroff CB.Recent advances in the neurobiology of depression.Psychopharmacol Bull.2002;36 Suppl 2:6-23
[13]Smith KA,Fairbum CG,Cowen PJ.Relapse of depression after rapid depletion of tryptophan.Lancet 1997,349(9056):915-919.
[14]龚绍麟.抑郁症.第一版,北京:人民卫生出版社,2003,131-141.
[15]郝伟.精神病学.第四版,北京:人民卫生出版社,2002,107-109.
[16]Manji HK,Drevets WC,Chamey DS.The cellular neurobiology of depression.Nat Med,2001,7(5):541-547.
[17]Neumeister A.Tryptophan depletion,Serotonin,and depression:where do we stand?.psychopharmacol Bull,2003,37(4):99-115
[18]张亚林.精神病学.第一版,北京:人民教育出版社,2005,266-271.
[19]喻东山.五羟色胺和精神药理.国外医学精神病学分册;2002,29(1):41-44.
[20]Hayden EP,Numberger JI Jr.Molecular genetics of bipolar disorder.Genes Brain Behav.2006,5(1):85-95.
[21]Levinson DF.The genetics of depression:a review.Biol Psychiatry.2006,60(2):84-92.
[22]Lesch KP,Bailing U,Gross J,et al.Organization of the human serotonin transporter gene.J Neural Transm Gen Sect,1994,95(2):157-162.
[23]Kirov G,Rees M,Jones I,et al.Bipolar disorder and the serotonin transporter gene:a family-based association study.Psychol Med,1999,29(5):1249-1254.
[24]Heils A,Teufel A,Petri S,et al.Allelic variation of human serotonin transporter gene expression.Neurochem,1996,66(6):2621-2624.
[25]Mackenzie A,Quinn J.A transporter gene intron 2 polymorphic region,correlated with affective disorders,has allele dependent differential enhancer-like properties in the mouse embryo.Proc Natl Acad Sci U S A,1999,96(26):15251-15255.
[26]Minov C,Baghai TC,Schiile C,et aI.Serotonin-2A-receptor and-transporter polymorphisms:lack of association in patients with major depression.Neurosci Lett,2001,303(2):119-122.
[28]Ohara K,Nagai M,Tsukamoto T,et al.Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders.Biol Psychiatry,1998,44(7):550-554.
[29]Lotrich FE,Pollock BG.Meta-analysis of serotonin transporter polymorphisms and affective disorders.Psychiatr Genet,2004,14(3):121-129.
[30]苏颖.5-羟色胺2A受体基因与疾病的关系.中国综合临床;2003:19(9):771-772.
[31]Kunugi H,Tatsumi M,Sakai T,et al.Serotonin transporter gene polymorphism and affective disorder.Lancet,1996,347(9011):1340.
[32]liu W,Gu N,Feng G,et al.Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese.Pharmacogenetics,1999,9(4):491-495.
[33]Yen FC,Hong CJ,Hou S J,et al.Association study of serotonin transporter gene VNTR polymorphism andmooddisorders,onsetageandsuicide attempts in a Chinese sample.Neuropsychobiology,2003,48(1):5-9.
[34]Arranz M,Collier D,Sodhi M,et al.Association between clozapine response and allelic variation in 5-HT2A receptor gene.Lancet,1995,346(8970):281-282.
[35]Zhang HY,Ishigaki T,Tani K,etal.Serotonin2A receptor gene polymorphism in mood disorders.Biol Psychiatry,1997,41(7):768-773.
[36]Arias B,Gasto C,Catalan R,et al.The 5-HT(2A)receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients.Am J Med Genet,2001,105(8):801-804.
[37]Lerer B,Segrnan RH,Tan EC,et al.Combined analysis of 635 patients confirms an age-related association of serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.Int J Neuropsychopharrnacol,2005,8(3):411-425.
[38]De Luca V,Likhodi O,Kennedy JL,et al.Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism:analysis of suicidality in schizophrenia and bipolar disorder.Am J Med Genet B Neuropsychiatr Genet.2007,144(3):370-374.
[39]Crabbe JC,Phillips TJ,Feller D J,et al.Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors.Nat Genet,1996,14(1):98-101.
[40]Bondy B,Kuznik J,Baghai T,et al.Lack of association of Serotonin 2A receptor gene polymorphism(T102C)with suicide ideation and suicide.Am J Med Genet,2000,96(6):831-835.
[41]Mahieu B,Souery D,Lipp O,et al.No association between bipolar affective disorder and a serotonin receptor(5-HT2A)polymorphism.Psychiatry Res,1997,70(2):65-69.
[42]Arranz MJ,Erdmann J,Kirov G,et al.5-HT_(2A)receptor and bipolar affective disorder:association studies in affected patients.Neurosci Lett.,1997,224(2):95-98.
[43]Turecki G,Briere R,Dewar K,et al.Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide.Am J Psychiatry,1999,156(9):1456-1458.
[44]Correa H,De Marco.L,Boson W,et al.Analysis of T102C 5-HT2A polymorphism in Brazilian psychiatric inpatients:relationship with suicidal behavior.Cell Mol Neurobiol,2002,22(5-6):813-817.
[45]Tan EC,Chong SA,Chan AO,et al.No efvidence for association of the T102C polymorphism in the Serotonin type 2A receptor with suicidal behavior in schizophrenia.Am J Med Genet,2002,114(3):321-322.
[46]Du L,Bakish D,Lapierre YD,et al.Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder.Am J Med Genet,2000,96(1):56-60.
[47]Du L,Faludi G,Palkovits M,et al.Serotonergic genes and suicidality.Crisis,2001,22(2):54-60.
[48]曹莉萍,李涛,许珂,等.自杀未遂与5一HT2A受体基因A-1438G多态性的关联研究.中国神经精神疾病杂志;2001,27:296-298.
[49]陶明,施慎逊,顾牛范.5-羟色胺受体的研究现状.中华精神科杂志;1998,31(3)184-186.
[50]Clark MS,McDevitt RA,Neumaier JF.Quantitative mapping of tryptophan hydroxylase-2,5-HT1A,5-HT1B,and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei.J Comp Neurol,2006,498(5):611-623.
[51]Rujescu D,Giegling I,Sato T,et al.Lack of association between serotonin5-HT1B receptor gene polymorphism and suicidal behavior.Am J Med Genet B Neuropsychiatr Genet,2003,116(1):69-71.
[52]Turecki G,Sequeira A,Gingras Y,et al.Suicide and serotonin:study of variation at seven serotonin receptor genes in suicide completers.Am J Med Genet B Neuropsychiatr Genet,2003,118(1):36-40.
[53]Nelson JC.A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression.Biol Psychiatry,1999,46(9):1301-1308.
[54]Blier P,Saint-Andre E,Hebert C,et al.Effects of different does of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.Int J Neuropsychopharmacol,2007,10(1):41-50.
[55]王传跃,翟屹民,翁永振,等.安非他酮与阿密替林治疗抑郁障碍的双盲对照研究.中华精神科杂志;2006,39(3)169-173
[56]DeBattista C,Solvason HB,Pokier J,et al.A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergicantidepressants.JClin Psychopharmacol.2003,23(1):27-30.
[57]Bauer M,Adli M,Baethge C,et al.Lithium augmentation therapy in refractory depression:clinical evidence and neurobiological mechanisms.Canadian Journal of Psychiatry,2003,48(7):440-448.
[58]Bauer M,Dopfmer S.Lithium augmentation in treatment-resistant depression:meta-analysis of placebo-controlled studies.Journal of Clinical Psychopharmacology,1999,19(5):427-434.
[59]Joffe RT,Singer W,Levitt AJ,et al.A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.Arch Gen Psychiatry,1993,50(5):387-393.
[60]张唯扬,郭先健.钙信号基本单位和特征的研究进展.生理科学进展,2000,31(2):109-114.
[61]刘景生.细胞信息与调控.第二版,北京:北京协和医科大学出版社,2004:283-338.
[62]I.B.莱维坦,L.K.卡茨玛克.(舒斯云,包新民译).神经元:细胞和分子生物学.第一版,北京:科学出版社,2001:185-205.
[63]刘煜,赵晓航,吴文.钙/钙调蛋白依赖性丝氨酸蛋白激酶的结构和功能.生物化学和生物物理进展,2002,29:14-18.
[64]许绍芬.神经生物学.第二版,上海:上海医科大学出版社,1999,185-200.
[65]鞠躬,吕国蔚,王百忍.神经生物学.第一版,北京:人民卫生出版社,2004:159-176.
[66]胡健,胡友梅.G蛋白亚单位基因家族研究进展.生理科学进展,2003,34(2):131-135
[67]Hepler JR.Emerging roles for RGS proteins in cell signalling.Trends Pharmacol Sci,1999,20(9):376-382.
[68]陈紫薇,杨奎,王韵,等.G蛋白偶联受体失敏及内吞相关蛋白的研究进展.生理科学进展,2001,32(1):55-58.
[69]鲍国斌,濮璐,,裴钢.G蛋白对离子通道的调控.生命的化学,1998,18(4):19-21.
[70]杜延顺,黄秉仁.G蛋白信号调节因子的结构分类与功能.生理科学,2005,36(3):215-219.
[71]喻东山.心境稳定剂的作用机制.国外医学精神病学分册,2000,27(4):211-215.
[72]Avissar S,Nechamkin Y,Barki-Harrington L,et al.Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent.Affect Disord,1997,43(2):85-93.
[73]Avissar S,Nechamkin Y,Roitman G,et al.Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression.Am J Psychiatry,1998,155(5):666-671.
[74]Alda M,Keller D,Grof E,et al.Is lithium response related to G(s)alpha levels in transformed lymphoblasts from subjects with bipolar disorder? J Affect Disord,2001,65(2):117-122.
[75]CelanoE,TiraboschiE,Consogno E,et al.Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase Ⅱ by psychotropic drugs.Biol psychiatry, 2003,53(3):442-449.
[76] Vargens DD, Almendra L, Struchiner CJ, et al. Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol, 2008,64(3): 253-256.
[77] Young LT, Li PP, Kamble A, et al. Lack of effect of antidepressants on mononuclear leukocyte G-protein levels or function in depressed outpatients.J Affect Disord, 1996, 39(3): 201-207.
[78] Avissar S, Nechamkin Y, Barki-Harrington L, et al.Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. J Affect Disord, 1997, 43 (2): 85-93.
[79] Young LT, Li PP, Kamble A, et al. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder.Am J Psychiatry, 1994,151(4): 594-596.
[80] Karege F, Bovier P, Stepanian R, et al.The effect of clinical outcome on platelet G proteins of major depressed patients .Eur Neuropsychopharmacol, 1998,8(2):89-94.
[81] Garcia-Sevilla JA, Ventayol P, Perez V, et al. Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depressionxffects of mirtazapine treatment. Neuropsychopharmacology, 2004,29(3):580-588.
[82] Hahn CG, Umapathy, Wang HY, et al. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.J Psychiatr Res, 2005, 39(4): 355-363.
[83] Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-Associated sexual side-effects. Neuropsychopharmacology, 2006, 31(10): 2281-2288.
[84] Johansson C, Willeit M, Aron L,et al .Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism. Biol Psychiatry, 2004, 55(3):317-319.
[85] Willeit M, Praschak-Rieder N, Zill P, et al. C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder. Biol Psychiatry, 2003,54(7): 682-686.
[86] Kunugi H, Kato T, Fukuda R, et al. Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders. J Neural Transm, 2002,109(2):213-218.
[87] 江开达．精神药理学．第一版．人民卫生出版社,北京2007
[88] Lowther S,Katona CL,Crompton MR, et al. Brain [3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants.Brain Res, 1997,758(1-2): 223-228.
[89] Mooney JJ, Samson JA,McHale NL, et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in. the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry,1998,43(8):574-583.
[90] Newman ME, Lerer B, Lichtenberg P, et al. Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology (Berl), 1992,109(2):231-234.
[91] van der Stelt HM, Broersen LM, Olivier B, et al Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl).2004,172(2):137-144.
[92] Menninger JA, Baron AE, Conigrave KM, et al. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism. Alcohol Clin Exp Res. 2000,24(6):810-821.
[93] Vetulani J, Sulser E Action of Various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in cimbic forebrain. Nature, 1975, 257(5526): 495-496.
[94] Xu Z, Seidler FJ, Cousins MM, et al. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res. 2002, 951(2) :280-292.
[95]李海燕,周东丰.电针和氟西汀治疗抑郁症对血小板蛋白激酶C的影响.中国心理卫生杂志,2004,18(10):688-691.
[96]许晶,刘晶.行为缺损抑郁大鼠脑环磷酸腺苷含量及蛋白激酶C表达的变化.中华精神科杂志,2002,35(3):173-176.
[97]许晶,马丽珍,王俊平.,抑郁症患者血小板蛋白激酶C水平的变化.临床精神医学杂志,2003,13(5):258-259.
[98]Hahn CG,Umapathy,Wang HY,et al.Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.J Psychiatr Res,2005,39(4):355-363.
[99]Hahn CG,Friedman E.Abnormalities in protein kinase C signaling and the patho- physiology of bipolar disorder.Bipolar Disord,1999,1(2):81-86.
[100]Duman R,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders.Biol Psychiatry,2000,48(8):732-739.
[101]Nibuya M,Nestler EJ,Duman RS.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus.Neurosci,1996,16(7):2365-2372.
[102]Thome J,Sakai N,Shin K,et al.cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.Neurosci,2000,20(11):4030-4036.
[103]Blom J,Tascedda F,Carra S,et al.Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function.Neuropsychopharmacology,2002,26(5):605-614.
[104]Shieh PB,Hu SC,Bobb K,et al.Identification of a signaling pathway involved in calcium regulation of BDNF expression.Neuron,1998,20(4):727-740.
[105]Tao X,Finkbeiner S,Arnold DB,et al.Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.Neuron,1998,20(4):709-726.
[106]Nestler E,Aghajanian GK.Molecular and cellular basis of addiction.Science,1997,278(5335):58-63.
[107] Milner B, Squire LR, Kandel ER. Cognitive neuroscience and the study of memory.Neuron,1998, 20(3):445-468.
[108] Silva A, Kogan JH, Frankland PW, et al. CREB and memory. Annu Rev Neurosci,1998,21:127-148.
[109] Chen A-H, Shirayama Y, Shin KH, et al. Expression of the cAMP response element binding protein (CREB) in hippocampus produces antidepressant effect.Biol Psychiatry 2001,49(9):753-762.
[110] Dowlatshahi D, MacQueen GM, Wang JF, et al. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet, 1998, 352(9142): 1754-1755.
[111] Rossby S, Manier DH, Liang S, et al.Venlafaxine; pharmacological actions. beyond aminergic receptors.Int J Neuropsychopharmacol,1999, 2(1):1-8.
[112] Manier D, Shelton RC, Sulser F. Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?.J Neural Transm, 2002,109(1):91-99.
[113] Pliakas A, Carlson RR, Neve RL, et al. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens. J Neurosci ,2001,21(18):7397-7403.
[114] Conti A, Cryan JF, Dalvi A, et al. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.J Neurosci ,2002,22(8):3262-3268.
[1]舒斯云,包新民译I.B.莱维坦,L.K.卡茨玛克.著神经元:细胞和分子生物学[M]第一版,北京:科学出版社,2001:185-205.
[2]刘景生.细胞信息与调控[M].第二版,北京:北京协和医科大学出版社,2004:283-338.
[3]Mitchell PB,Manji HK.High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder[J].Am J Psychiatry,1997,154(2):218-223.
[4]A lda M,et,al,Is lithium response related to Gs alpha levels in transformed lymphoblasts form subjects with bipolar disorder? Affective Disord 2001;65(2):117-122
[5]Celaano E,et,al.Selectively regulartion of presynaptic calcium lcalmodulin-dependent predent protein dinase Ⅱ by psychopic drugs.biol psychiatry.2003.53(3)442-449
[6]Schreiber G,Avissar S.G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders[J].Isr Med Assoc J,2002:86-91.
[7]Levinson DF.The genetics of depression:a review.Biol Psychiatry.2006 Jul 15;60(2):84-92.
[8].Hayden EP,Nurnberger JI Jr.Molecular genetics of bipolar disorder.Genes Brain Behav.2006;5(1):85-95.
[9]胡健,胡友梅.G蛋白亚单位基因家族研究进展.[J]生理科学进展,2003,34(2):131-135.
[10]Willeit M,Praschak-Rieder N,Zill P,et al.C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder[J].Biol Psychiatry.2003 Oct 1;54(7):682-686.
[11]Bishop JR,Moline J,Ellingrod VL,et al.Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-Associated sexual side-effects[J].Neuropsychopharmacology,2006,31(10):2281-2288.
[12] Tsiouris SJ, Breschel TS, Xu i,et al. Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder[J]. Am J Med Genet,1996,67(5):491-494.
[13] Ram A, Guedj F, Cravchik A,et al. No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder [J]. Arch Gen Psychiatry, 1997,54(1):44-48.
[14] Saito T, Papolos DF, Chernak D,et al. Analysis of GNAZ gene polymorphism in bipolar affective disorder[J]. Am J Med Gene, 1999,88(4):324-328.
[15] Zill P, Engel R, Baghai TC,et al.Analysis of polymorphisms in the olfactory G-protein Golf in major depression[J]. Psychiatr Genet, 2002,12(1):17-22.
[16] Zill P, Baghai TC, Zwanzger P,et al. Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression[J]. Am J Med Genet,2002,114(5):530-532.
[17] Zill P, Malitas PN, Bondy B,et al. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients[J]. Psychiatr Genet, 2003,13(2):65-69.
[18] Spleiss O, van Calker D .Abnormal G protein alpha(s) - and alpha(i)-subunit mRNA expression in bipolar affective disorder[J].Mol Psychiatry, 1998,3(6):512- 520.
[19] Zill P, Baghai TC, Zwanzger Y,et al. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment[J]. Neuroreport, 2000,11(9):1893-1897.
[20] Willeit M, Praschak-Rieder N, Zill ?,et al. C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder [J]. Biol Psychiatry. 2003;54(7):682-686.
[21] Lee HJ, Cha JH, Ham BJ,et al. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders[J]. Pharmacogenomics J,2004,4(1):29-33.
[22] Serretti A, Lorenzi C, Cusin C,et al. SSRIs antidepressant activity is influenced by G beta 3 variants[J]. Eur Neuropsychopharmacol. 2003,13(2):117-122.
[23] Joyce PR,Mulder RT,Luty SE,et al. Age-dependent antidepressant pharmaco- genomics:polymorphisms of the serotonin transporter and G protein beta3subunit as predictors of response to fluoxetine and nortriptyline[J].Int J Neuropsy- chopharmacol,2003,6(4):339-346.
[24]Exton MS,Artz M,Siffert W,et al.G protein beta3 subunit 825T allele is associated with depression in young,healthy subjects[J].Neuroreport,2003,14(3):531-533.
[25]Johansson C,Willeit M,Aron L,et al.Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism[J].Biol Psychiatry,2004,55(3):317-319.
[26]Kunugi H,Kato T,Fukuda R,et al.Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders[J].J Neural Transm,2002,109(2):213-218.
[27]Lin CN,Tsai SJ,Hong CJ.Association analysis of a functional G protein beta3subunit gene polymorphism(C825T)in mood disorders[J].Neuropsychobiology,2001,44(3):118-121.
[27]肖红,姚毁,郭素婉,等.G蛋白β3亚基基因C825T多态性与抑郁症及SSRI 和SNRI类抗抑郁药的关系.中国临床药理学杂志2002;18(6)414-416。
[2]贾福军,胡宪章.精神医学与神经病学.郑州:河南医科大学出版社,2000.
[3]郝伟.精神病学.第四版,北京:人民卫生出版社,2002,107-109.
[4]Neumeister A.Tryptophan depletion,Serotonin,and depression:where do we stand?.psychopharmacol Bull,2003,37(4):99-115.
[5]王雪琦,路长林,李丽云等.大鼠抑郁模型的脑磁共振成像研究.中华精神科杂志,1999,32(1):12-14.
[6]Blier E Pharmacology of Rapid-Onset Antidepressant Treatment Strategieso.J Clin Psychiatry.2001,62 Suppl 15:12-17.
[7].Fricker AD,Rios C.Serotonin receptor activation leads to neurite outgrowth and neuronal survival.Brain Res Mol Brain Res.2005,18,138(2):228-235.
[8]Slotkin TA,Cousins MM,Serotonergic cell signaling in an animal model of aging and depression:olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats.Neuropsychopharmacology.2005,30(1):52-57.
[9]Lahshmi N,Yutham,Peter F,et al.Brain Serotonin Receptors in Major Depression A Positron Emission Tomography Study.Arch Gert Psychiatly,2000,57:850-858.
[10]江开达.精神药理学,第一版,北京:人民卫生出版社,2007.
[11]姚树桥.医学心理学与精神病学,第二版,北京:人民卫生出版社,2007。
[12]Chen Z,Skolnick P.Triple uptake inhibitors:therapeutic potential in depression and beyond.Expert Opin Investig Drugs.2007,16(9):1365-1377.
[13]龚绍麟.抑郁症.第一版,北京:人民卫生出版社,2003.
[14]Cheng Z,Sheldrick EL,Marshall E,et al.Control of cyclic AMP concentration in bovine endometrial stromal cells by arachidonic acid.Reproduction,2007,133(5):1017-1026.
[15]金光亮,周东丰,郭霞珍,等.慢性利血平抑郁模型大鼠脑内游离钙离子、
钙调素和环核苷酸含量的变化.中华精神科杂志,1997,30(5):67-69.
[16]许绍芬主编.神经生物学.第二版,上海:上海科技出版社,2003.
[17]Schreiber G,Avissar S.G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders.Isr Med Assoc J,2000,2Suppl:86-91.
[18]Avissar S,Nechamkin Y.Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression.Am J Psychiatry,1997,154(2):211-217.
[19]Young LT,Li PP,Kish SJ,et.al.Cerebral Hex Gs alpha preteiilevels and forskolin-stimulated cyclic AMP formation are ilwrcasedin bipolar affective disorder.J Neurochem,1993,61(3 1):890-898.
[20]Young LT,Li PP,Kamble A,et al.Lack of effect of antidepressants on mononuclear leukocyte G-protein level or function in depressed outpatients.Affect Disord,1996,39(3):201-207.
[21]Menninger JA,Tabakoff B.Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with majo rdepression.Biol Psychiatry,1997,42(1):30-38.
[22]Montezinho LP,MΦrk A,Duarte CB,et al.Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.Bipolar Disord,2007,9(3):290-297.
[23]Matowe WC,Ananthalakshmi KV,Kombian SB,et al.Role of protein kinase C in substance P-induced synaptic depression in the nucleus accumbens in vitro.Med Princ Pract.,2007,16(2):90-99.
[24]Gould TD,Manji HK.Signaling networks in the pathophysiology and treatment of mood disorders.Psychosom Res,2002,53(2):687-697.
[25]Hines LM,Tabakoff B.WHO/ISBR A Study on State and Trait Markers of Alcohol Use and Dependence Investigators Platelet adenylyl cyclase activity:a biological marker for major depression and recent drug use.BiolPsychiatry,2005,58(12):955-962.
[26] Newman ME, Lerer B, Lichtenberg P, et al. Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology, 1992,109(2): 231-234.
[27] Mooney JJ, Samson JA, McHale NL, et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in the coordinated integration of cellular signals.Biol Psychiatry, 1998, 43(8): 574-583.
[28] Boer U, Cierny I, Krause D, Heinrich A, et al..Chronic Lithium Salt Treatment Reduces CRE/CREB-Directed Gene Transcription and Reverses Its Upregulation by Chronic Psychosocial Stress in Transgenic Reporter Gene Mice. Neuropsychopharmacology, 2007 Nov 28.
[29] Nibuya M, Ncstler EJ, Duman RS, et al.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB) in rat hippocampus. J Neurosci, 1996,16 : 2365-2372.
[30] Levinson DF.The genetics of depression: a review. Biol Psychiatry, 2006, 60(2): 84-92.
[31] Laje G, Paddock S, Manji H, et al.Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry, 2007,164(10): 1530-1538.
[32] Harvey M, Belleau P, Barden N, et al.Gene interactions in depression: pathways out of darkness.Trends Genet, 2007, 23(11): 547-556.
[33] Hayden EP, Nurnberger JI Jr. Molecular genetics of bipolar disorder.Genes Brain Behav. 2006,5(1): 85-95.
[34] Lee HJ, Cha JH, Ham BJ, et al. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics, 2004,4(1): 29-33.
[35] Johansson C, Willeit M, Aron L, et al.Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism. Biol Psychiatry, 2004, 55(3): 317-319.
[36] Millar JK, Pickard BS, Mackie S, et al. DISCI and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP Signaling.Science,2005,310(5751):1187-1191.
[37]Hines LM,Hoffman PL,Bhave S,et al.A sex-specific role of type Ⅶ adenylyl cyclase in depression.J Neurosci,2006,26(48):12609-12619.
[38]Hellevuo K,Welbom R,Menninger JA,et al.Human adenylyl cyclase type 7contains polymorphic repeats in the 3' untranslated region:investigations of association with alcoholism.Am J Med Genet,1997,74(1):95-98.
[39]Zubenko GS,Hughes HB 3rd,Stiffler JS,et al Sequence variations in CREB1cosegregate with depressive disorders in women.Mol Psychiatry,2003,8(6):611-618.
[40]刘晓华.抑郁症遗传模式及其与CREBl_BDNF 基因的关联和表达研究.优秀博士论文数据库,2006.
[41]Ogden CA,Rich ME,Schork NJ,et al.Candidate genes,pathways and mechanisms for bipolar(manic-depressive)and related disorders:an expanded convergent functional genomics approach.Mol Psychiatry,2004,9(11):1007-1029.
[42]陈彦方.中国精神疾病诊断与分类标准(第三版).济南:山东科学出版社,2001,83-91.
[43]庞天鉴译.美国精神科学会DSM-IV分类与诊断标准.2001,130-160.
[44]张明园.精神科评定量表手册.长沙:湖南科学技术出版社,1993,81-127.
[45]冯作化主编.医学分子生物学.第一版,北京:人民卫生出版社,2003,184-197
[46]Cargill M,Altshuler D,Ierland J,et al.Characterization of single-nucleotide polymorphisms in coding regions of human genes.Nature Genet,1999,22(3):231-238.
[47]Lander ES.The new genomics:global views of biology.J Science,1996,274(5887):536-539.
[48]耿茜,蒋伟莹.人类基因组单体型图计划及其意义.国外医学遗传学分册,2005,28(1):1-5.
[49]http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=6311.
[50]Stein DJ,Hemmings S,Moolman-Srnook H,et al.5-HT2A:its role in frontally mediated executive function and related psychopathology.CNS Spectr,2007,12(7):512-516.
[51]Arias B,Gasto C,Catalan R,et al.The 5-HT(2A)receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients.Am J Med Genet,2001,105(8):801-804.
[52]Rosel P,Arranz B,Urretavizcaya M,et al.Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suidde victims.Neumpsychobiology,2004,49(4):189-195.
[53]Arranz MJ,Erdmann J,Kirov G,et al.5-HT2A receptor and bipolar affective disorder:association studies in affected patients.Neurosci Lett,1997,224(2):95-98.
[54]Warrington L,Lombardo I,Loebel A,et al.Ziprasidone for the treatment of acute manic or mixed episodes associated with bipolar disorder.CNS Drugs,2007,21(10):835-849.
[55]Enoch MA,Goldman D,Barnett R,et al.Association between seasonal affective disorder and the 5-HT2A promoter polymorphism1438G/A.Mol Psychiatry,1999,4(1):89-92.
[56]Du L,Bakish D,Lapierre YD,et al.Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder.Am J Med Genet,2000,96(1):56-60.
[57]Sher L.Possible genetic link between eating disorders and seasonal changes in mood and behavior.Med Hypotheses,2001,57(5):606-608.
[58]Fukuda Y,Koga M,Arai M,et al.Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes.Biol Psychiatry,2006,60(12):1331-1335.
[59]Bondy B,Buettner A,Zill P.Genetics of suicide.Mol sychiatry,2006,11(4):336-351.
[60]Jokela M,Keltikangas-Jarvinen L,et al.Serotonin receptor 2A gene and the,influence of childhood maternal nurturance on adulthood depressive symptoms.Arch Gen Psychiatry,2007,64(3):356-360.
[61]Serretti A,Calati R,Giegling I,et al.5-HT2A SNPs and the Temperament and Character Inventory.Prog Neuropsychopharrnacol Biol Psychiatry,2007,31(6):1275-1281.
[62]De Luca V,Likhodi O,Kennedy JL,et al.Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism:analysis of suicidality in schizophrenia and bipolar disorder.Am J Med Genet B Neuropsychiatr Genet,2007,144(3):370-374.
[63]Giegling I,Hartmann AM,M611er HJ,et aI.Anger-and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene.J Affect Disord.,2006,96(1-2):75-81.
[64]胡健,胡友梅.G蛋白亚单位基因家族研究进展.生理科学进展,2003,34(2):131-135.
[65]Zill P,Baghai TC,Zwanzger P,et al.Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment.Neuroreport,2000,11(9):1893-1897.
[66]Lin CN,Tsai S J,Hong CJ.Association analysis of a functional G protein beta3subunit gene polymorphism(C825T)in mood disorders.Neuropsychobiology,2001,44(3):118-121.
[67]Kunugi H,Kato T,Fukuda R,et al.Association study of C825T polymorphism of the G-protein 133 subunit gene with schizophrenia and mood disorders.J Neural Transm,2002,109(2):213-218.
[68]肖红,姚辉,郭素婉,等.G蛋白β3亚基基因C825T多态性与抑郁症及SSRI和SNRI类抗抑郁药的关系.中国临床药理学杂志,2002,18(6):414-416.
[69]Willeit M,Praschak-Rieder N,Zill P,et al.C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder.Biol Psychiatry,2003,54(7):682-686.
[70]Vargens DD,Almendra L,Struchiner CJ,et al.Distribution of the GNB3825C＞Tpolymorphism among Brazilians:impact of population structure.Eur J Clin Pharmacol,2008,64(3):253-256.
[71]Sami Anttila,Olli Kampman,Ari Illi,et al.Association between 5-HT2A,TPH1 and GNB3 genotypes and response to typical neuroleptics:a serotonergic approach.BMC Psychiatry,2007,7(1):22-28.
[72]鞠躬,吕国蔚,王百忍.神经生物学.第一版,北京:人民卫生出版社,2004:159-176.
[73]Cowburn RF,Marcusson JO,Eriksson A,et al.Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims.Brain Res,1994,633(1-2):297-304.
[74]Mizrahi C,Stojanovic A,Urbina M,et al.Differential cAMP levels and serotonin effects in blood peripheral mononuclear cells and lymphocytes from major depression patients.Int Immunopharmacol,2004,4(8):1125-1133.
[75]Toyota T,Hattori E,Meerabux J,et al.Molecular analysis,mutation screening,and association study of adenylate cyclase type 9 gene(ADCY9)in mood disorders.Am J Med Genet,2002,14(1):84-92.
[76]Gros R,Van Uum S,Hutchinson-Jaffe A,et al.Increased enzyme activity and beta-adrenergic mediated vasodilation in subjects expressing a single-nucleotide variant of human adenylyl cyclase 6.Arterioscler Thromb Vasc Biol.2007,27(12):2657-63.
[77]Hacker BM,Tomlinson JE,Wayman GA,et al.Cloning,chromosomal mapping,and regulatory properties of the human type 9 adenylyl cyclase(ADCY9).Genomics,1998,50(1):97-104.
[78]Cumbay MG,Watts VJ.Novel regulatory properties of human type 9 adenylate cyclase.J Pharmacol Exp Ther,2004,310(1):108-115.
[79]Ewald H,Mors O,Flint T,et al.A possible locus for manic depressive illness on chromosome 16p13.Psychiatr Genet,1995,5(2):71-81.
[80]Mclnnes LA,Escamilla MA,et al.A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees.Proc Natl Acad Sci U S A,1996,93(23):13060-13065.
[81]Toyota T,Yamada K,Saito K,et al.Association analysis of adenylate cyclase type 9 gene using pedigree disequilibrium test in bipolar disorder.Mol Psychiatry,2002,7(5):450-452.
[82]Lefievre L,de Lamirande E,Gagnon C.Presence of Cyclic nucleotide phosphodiesterases PDEiA,existing as a stable complex with calmodulin,and PDE3A in human spermatozoa.Biol Reprod,2002,67(2):423-430.
[83]田慧,张奇,朱景申.新的磷酸二酯酶及其功能.中国临床药理学杂志,2003,19(6):458-460.
[84]Nagel DJ,Aizawa T,Jeon KI,et al.Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival.Circ Res,2006,98(6):777-784.
[85]Perlis RH,Purcell S,Fava M,et al.Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR~*D study.Arch Gen Psychiatry,2007,64(6):689-697.
[86]张亚林主编.高级精神学.第一版,长沙:中南大学出版社,2007,377-415.
[87]喻东山.五羟色胺和精神药理.国外医学精神病学分册,2002,29(1):41-44.
[88]Itoh T,Tokumura M,Abe K.Effects of rolipram,a phosphodiesterase 4 inhibitor,in combination with imipramine on depressive behavior,CRE-binding activity and BDNF level in learned helplessness rats.Eur J Pharmacol,2004,498(1-3):135-142.
[89]Renau TE.The potential of phosphodiesterase 4 inhibitors for the treatment of depression:opportunities and challenges.Curr Opin Investig Drugs,2004,5(1):34-39.
[90]Kakkar R,Raju RV,Sharma RK.Calmodulin-dependent cyclic nucleotide phosphodiesterase(PDE1).Cell Mol Life Sci,1999,55(8-9):1164-1186.
[91]Michibata H,Yanaka N,Kanoh Y,et al.Human Ca2+/calmodulin-dependent phosphodiesterase PDE1A:novel splice variants,their specific expression,genomic organization,and chromosomal localization.Biochim Biophys Acta,2001,1517(2):278-287.
[92]Wong ML,Whelan F,Deloukas P,et al.Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response.Proc Natl Acad Sci U S A,2006,103(41):15124-15129.
[93]Teranishi KS,Slager SL,Garriock H,et al.Variants in PDEllA and PDE1A are not associated with citalopram response.Mol Psychiatry,2007,12(12):1061-1063.
[94]Saeki K,Yuo A.Distinct involvement of cAMP-response element-dependent t ranscriptions in functional and morphological mat uration during retinoid-mediated human myeloid differentiation.Journal of Leukocyte Biology,2003,73(5):673-681.
[95]Studzinski GP,Harrison LE.Differentiation-related changes in the cell cycle traverse.Int Revc yetol,1999,189:1-58.
[96]李璞主编.医学遗传学.第二版,北京:中国协和医科大学出版社,2006,419-437。
[97]Chen A-H,Shirayama Y,Shin K-H,et al.Expression of the cAMP response element binding protein(CREB)in hippocampus produces antidepressant effect.Biol Psychiatry,2001,49:753-762.
[98]Dowlatshahi D,MacQueen GM,Wang JF,et aI.Increased temporal cortex CREB concentrations and antidepressant treatment in major depression.Lancet,1998,352:1754-1755.
[99]Duman R,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders.Biol Psychiatry,2000,480:732-739.
[100]Rossby S,Manier DH,Liang S,et al.Venlafaxine pharmacological actions beyond aminergic receptors.Int J Neuropsychopharmacol,1999,2(1):1-8.
[101]Manier D,Shelton RC,Sulser E Noradrenergic antidepressants:does chronic treatment increase or decrease nuclear CREB-P? J Neural Transm,2002,109(1):91-99.
[102]Pliakas A,Carlson RR,Neve RL,et al.Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens.J Neurosci,2001,21(18):7397-7403.
[103]Conti A,Cryan JF,Dalvi A,et al.cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription,but not the behavioral or endocrine responses to antidepressant drugs.J Neurosci ,2002,22(8) :3262-3268.
[104] Laifenfeld D, Karry R, Grauer E, et al. Antidepressants and prolonged stress in rats modulate CAM-L1, laminin, and pCREB, implicated in neuronal plasticity.Neurobiol Dis, 2005 ,20(2):432-441.
[105] Reagan LP,Hendry RM,Reznikov LR,et al.Tianeptine increases brain-derived neurotrophic factor expression in the rat amygdala. Eur J Pharmacol, 2007,565(1-3):68-75.
[106] Thome J, Sakai N, Shin KH, et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci , 2000, 20(11): 4030-4036.
[107] Blom J, Tascedda F, Carra S, et al. Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function. Neuropsychopharmacology, 2002, 26(5): 605-614.
[108] Shieh PB, Hu SC, Bobb K, et al. Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron,1998,20(4):727-740.
[109] Tao X, Finkbeiner S, Arnold DB, et al. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron,1998,20:709-726.
[110] Nestler E,Aghajanian GK. Molecular and cellular basis of addiction. Science,1997, 278(5335):58-63.
[111] Milner B, Squire LR, Kandel ER, et al. Cognitive neuroscience and the study of memory. Neuron,1998,20(3):445-468.
[112] Silva A,Kogan JH,Frankland PW, et al. CREB and memory. Annu Rev Neurosci 1998,21:127-148.
[113] Zubenko GS,Hughes HB 3rd ,Maher BS, et al. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet,2002,114(8):980 -987.
[114]Zubenko GS,Maher B,Hughes HB 3rd,et al.Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent,early-onset,major depression.Am J Med Genet B Neuropsychiatr Genet,2003,123(1):1-18.
[115]Burcescu I,Wigg K,King N,Vetro A,et al.Association study of CREB1 and childhood-onset mood disorders.Am J Med Genet B Neuropsychiatr Genet,2005,137(1):45-50.
[116]Zubenko GS,Hughes HB 3rd.Effects of the G(-656)A variant on CREB1promoter activity in a glial cell line:Interactions with gonadal steroids and stress.Am J Med Genet B Neuropsychiatr Genet,2008 Jan 22.
[117]Oelke M,Hedlund P,Albrecht K,et al.Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3,4,and 5 in the human clitoris:immunohistochemical and molecular biology study.Urology,2006,67(5):1111-1116.
[118]Lippmann M,Bress A,Nemeroff CB,et al.Long-term behavioural and molecular alterations associated with maternal separation in rats.Eur J Neurosci,2007,25(10):3091.
[119]Blendy JA.The Role of CREB in Depression and Antidepressant Treatment.Biological Psychiatry,2006,59(12):1144-1150.
[120]Perlis RH,Purcell S,Fagerness J,et al.Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder.Biol Psychiatry,2007,62(5):536-540.
[121]Gass P,Riva MA.CREB,neurogenesis and depression.Bioessays,2007,29(10):7-961.
[122]Young LT,Bezchlibnyk YB,Chen B,Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders:effects of diagnosis,suicide,and drug treatment.Biol Psychiatry,2004,55(6):570-577.
[123]潘阳,叶菜英,张德昌.G蛋白异二聚体与跨膜信号转导的保真.国外医学 分子生物学分册,2003,25(5):279-281.
[124]Mamdani F,Alda M,Grof P,et al.Lithium response and genetic variation in the CREB family of genes.Am J Med Genet B Neuropsychiatr Genet,2008 Jan 11.
[125]Kato T.Molecular genetics of bipolar disorder and depression.Psychiatry Clin Neurosci,2007,61(1):3-19.
[126]Blackwood DH,Pickard BJ,Thomson PA,et al.Are some genetic risk factors common to schizophrenia,bipolar disorder and depression? Evidence from DISC1,GRIK4 and NRG1.Neurotox Res,2007,11(1):73-83.
[127]Ueno S,Iga J,Numata S,So K,et al.Genetic aspects of depressive disorder.Seishin Shinkeigaku Zasshi,2007,109(9):859-863.
[128]张文彤主编.SPSS11统计分析教程.北京:北京希望电子出版社,2002,124-210.
[129]Demyttenaere K,De Fruyt J,Stahl SM.The many faces of fatigue in major depressive disorder.Int J Neuropsychopharmacol,2005,8(1):93-105.
[130]Tylee A,Gastpar M,Lepine JP,et al.Identification of depressed patient types in the community and their treatment needs:findings from the DEPRES Ⅱ(Depression Research in European Society II)survey.DEPRES Steering Committee.Int Clin Psychopharmacol,1999,14(3):153-165.
[131]Dickel,J.Veenstra-VanderWeele,N.Bivens,X.et al.Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder.Biol Psychiatry,2007,61(3):322-329.
[132]Unschuld PG,Ising M,Erhardt A,et al.Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder.Am J Med Genet B Neuropsychiatr Genet,2007,144(4):424-429.
[133]Wasserman D,Geijer T,Sokolowski M,et aL Nature and nurture in suicidal behavior,the role of genetics:some novel findings conceming personality traits and neural conduction.Physiol Behav,2007,92(1-2):245-249.
[134]Goldstein TR,Bridge JA,Brent DA.Sleep disturbance preceding completed suicide in adolescents.J Consult Clin Psychol,2008,76(1):84-91.
[135]Alloy LB,Abramson LY,Whitehouse WG,et al.Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression..J Abnorm Psychol,2006,115(1):145-156.
[136]Chellappa SL,Aratijo JF.Sleep disorders and suicidal ideation in patients with depressive disorder.Psychiatry Res,2007,153(2):131-136.
[137]Liu X,Buysse DJ.Sleep and youth suicidal behavior:a neglected field.Curr Opin Psychiatry,2006,19(3):288-293.
[138]Bernert RA,Joiner TE Jr,Cukrowicz KC,et aI.Suicidality and sleep disturbances.Sleep,2005,28(9):1039-1040.
[139]Bagby RM,Psych C,Quilty LC,et al.Personality and depression.Can J Psychiatry,2008,53(1):14-25.
[140]Samochowiec J,Fiszer-Piosik E,Kucharska-Mazur J,et al.The influence of genes on the development of personality.Psychiatr Pol,2000,34(1):99-109.
[141]Ham BJ,Kim YH,Choi MJ,et al.Serotonergic genes and personality traits in the Korean population.Neurosci Lett,2004,354(1):2-5.
[142]Soloff PH,Price JC,Meltzer CC,et al.5HT2A receptor binding is increased in borderline personality disorder.Biol Psychiatry,2007,62(6):580-587.
[143]Chang HJ,Yang CY,Lin CR,et al.Determinants of suicidal ideation in taiwanese urban adolescents.J Formos Med Assoc,2008,107(2):156-164.
[144]Chang HJ,Lin MF,Lin KC.The mediating and moderating roles of the cognitive triad on adolescent suicidal ideation.Nurs Res,2007,56(4):252-259.
[145]Demyttenaere K,Adelin A,Patrick M,et al.Six-month compliance with antidepressant medication in the treatment of major depressive disorder.Int Clin Psychopharmacol,2008,23(1):36-42.
[146]梅玲玲,蒋锋,王传跃.重性抑郁症的内表型及其进展.国际精神病学杂志,2006,33(1):35-36.
[147]Wilkie MJ,Smith D,Reid IC,et al.A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.Pharmacogenet Genomics,2007,17(3):207-215.
[148]Crossley NA,Bauer M.Acceleration and augmentation of antidepressants with lithium for depressive disorders:two meta-analyses of randomized,placebo-controlled trials.J Clin Psychiatry,2007,68(6):935-940.
[149]Guzzetta F,Tondo L,Centorrino F,et al.Lithium treatment reduces suicide risk in recurrent major depressive disorder.J Clin Psychiatry,2007,68(3):380-383.
[150]刘景生主编.细胞信息与调空.第二版,北京:中国协和大学出版社,2004,235-338.
[151]Iwatsubo K,Okumura S,Ishikawa Y.Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling.Endocr Metab Immune Disord Drug Targets,2006,6(3):239-247.
[152]Gros R,Ding Q,Cao H,et al.Feldman RD Identification of a dysfunctional missense single nucleotide variant of human adenylyl cyclase Ⅵ.Clin Pharmacol Ther,2005,77(4):271-278.
[1]王学铭.精神与精神疾病的生物化学.第一版,北京:人民卫生出版社,2002,160-167.
[2]李东亮,张朝.基础神经生物学.第一版,北京:人民军医出版社,2007,113-115.
[3]姚泰.生理学.第一版,北京:人民卫生出版社,2005,410-410.
[4]Greenshaw A J,Silverstone PH.The non-antiemetic uses of serotonin 5-HT3receptor antagonists.Clinical pharmacology and therapeutic applications.Drugs,1997,53(1):20-39.
[5]Russo S,Kema IP,Fokkema MR,et al.Tryptophan as a link between psychopathology and somatic states.Psychosom Med,2003,65(4):665-671.
[6]Fink KB,G6thert M.5-HT receptor regulation of neurotransmitter release.Pharmacol Rev.2007,59(4):360-417.
[7]Fricker AD,Rios C,Devi LA,et al.Serotonin receptor activation leads to neurite outgrowth and neuronal survival.Brain Res Mol Brain Res.2005,138(2):228-235.
[8]Katona CL,Abou-Saleh MT,Harrison DA,et a/.Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.British of Psychiatry,1995,166(1):80-86.
[9]沈渔村.精神病学.第四版,北京:人民卫生出版社,2002,23-28.
[10]Brown GL,Linnoila MI.CSF serotonin metabolite(5-hIAA)studies in depression,impulsivity,and violence.Clin Psychiatry.1990,51 Suppl:31-41
[11]刘协和,袁德基.牛津精神病学教科书(中文版).第一版,四川:四川大学出版社,2004,287-296.
[12]Nemeroff CB.Recent advances in the neurobiology of depression.Psychopharmacol Bull.2002;36 Suppl 2:6-23
[13]Smith KA,Fairbum CG,Cowen PJ.Relapse of depression after rapid depletion of tryptophan.Lancet 1997,349(9056):915-919.
[14]龚绍麟.抑郁症.第一版,北京:人民卫生出版社,2003,131-141.
[15]郝伟.精神病学.第四版,北京:人民卫生出版社,2002,107-109.
[16]Manji HK,Drevets WC,Chamey DS.The cellular neurobiology of depression.Nat Med,2001,7(5):541-547.
[17]Neumeister A.Tryptophan depletion,Serotonin,and depression:where do we stand?.psychopharmacol Bull,2003,37(4):99-115
[18]张亚林.精神病学.第一版,北京:人民教育出版社,2005,266-271.
[19]喻东山.五羟色胺和精神药理.国外医学精神病学分册;2002,29(1):41-44.
[20]Hayden EP,Numberger JI Jr.Molecular genetics of bipolar disorder.Genes Brain Behav.2006,5(1):85-95.
[21]Levinson DF.The genetics of depression:a review.Biol Psychiatry.2006,60(2):84-92.
[22]Lesch KP,Bailing U,Gross J,et al.Organization of the human serotonin transporter gene.J Neural Transm Gen Sect,1994,95(2):157-162.
[23]Kirov G,Rees M,Jones I,et al.Bipolar disorder and the serotonin transporter gene:a family-based association study.Psychol Med,1999,29(5):1249-1254.
[24]Heils A,Teufel A,Petri S,et al.Allelic variation of human serotonin transporter gene expression.Neurochem,1996,66(6):2621-2624.
[25]Mackenzie A,Quinn J.A transporter gene intron 2 polymorphic region,correlated with affective disorders,has allele dependent differential enhancer-like properties in the mouse embryo.Proc Natl Acad Sci U S A,1999,96(26):15251-15255.
[26]Minov C,Baghai TC,Schiile C,et aI.Serotonin-2A-receptor and-transporter polymorphisms:lack of association in patients with major depression.Neurosci Lett,2001,303(2):119-122.
[28]Ohara K,Nagai M,Tsukamoto T,et al.Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders.Biol Psychiatry,1998,44(7):550-554.
[29]Lotrich FE,Pollock BG.Meta-analysis of serotonin transporter polymorphisms and affective disorders.Psychiatr Genet,2004,14(3):121-129.
[30]苏颖.5-羟色胺2A受体基因与疾病的关系.中国综合临床;2003:19(9):771-772.
[31]Kunugi H,Tatsumi M,Sakai T,et al.Serotonin transporter gene polymorphism and affective disorder.Lancet,1996,347(9011):1340.
[32]liu W,Gu N,Feng G,et al.Tentative association of the serotonin transporter with schizophrenia and unipolar depression but not with bipolar disorder in Han Chinese.Pharmacogenetics,1999,9(4):491-495.
[33]Yen FC,Hong CJ,Hou S J,et al.Association study of serotonin transporter gene VNTR polymorphism andmooddisorders,onsetageandsuicide attempts in a Chinese sample.Neuropsychobiology,2003,48(1):5-9.
[34]Arranz M,Collier D,Sodhi M,et al.Association between clozapine response and allelic variation in 5-HT2A receptor gene.Lancet,1995,346(8970):281-282.
[35]Zhang HY,Ishigaki T,Tani K,etal.Serotonin2A receptor gene polymorphism in mood disorders.Biol Psychiatry,1997,41(7):768-773.
[36]Arias B,Gasto C,Catalan R,et al.The 5-HT(2A)receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients.Am J Med Genet,2001,105(8):801-804.
[37]Lerer B,Segrnan RH,Tan EC,et al.Combined analysis of 635 patients confirms an age-related association of serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.Int J Neuropsychopharrnacol,2005,8(3):411-425.
[38]De Luca V,Likhodi O,Kennedy JL,et al.Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism:analysis of suicidality in schizophrenia and bipolar disorder.Am J Med Genet B Neuropsychiatr Genet.2007,144(3):370-374.
[39]Crabbe JC,Phillips TJ,Feller D J,et al.Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors.Nat Genet,1996,14(1):98-101.
[40]Bondy B,Kuznik J,Baghai T,et al.Lack of association of Serotonin 2A receptor gene polymorphism(T102C)with suicide ideation and suicide.Am J Med Genet,2000,96(6):831-835.
[41]Mahieu B,Souery D,Lipp O,et al.No association between bipolar affective disorder and a serotonin receptor(5-HT2A)polymorphism.Psychiatry Res,1997,70(2):65-69.
[42]Arranz MJ,Erdmann J,Kirov G,et al.5-HT_(2A)receptor and bipolar affective disorder:association studies in affected patients.Neurosci Lett.,1997,224(2):95-98.
[43]Turecki G,Briere R,Dewar K,et al.Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide.Am J Psychiatry,1999,156(9):1456-1458.
[44]Correa H,De Marco.L,Boson W,et al.Analysis of T102C 5-HT2A polymorphism in Brazilian psychiatric inpatients:relationship with suicidal behavior.Cell Mol Neurobiol,2002,22(5-6):813-817.
[45]Tan EC,Chong SA,Chan AO,et al.No efvidence for association of the T102C polymorphism in the Serotonin type 2A receptor with suicidal behavior in schizophrenia.Am J Med Genet,2002,114(3):321-322.
[46]Du L,Bakish D,Lapierre YD,et al.Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder.Am J Med Genet,2000,96(1):56-60.
[47]Du L,Faludi G,Palkovits M,et al.Serotonergic genes and suicidality.Crisis,2001,22(2):54-60.
[48]曹莉萍,李涛,许珂,等.自杀未遂与5一HT2A受体基因A-1438G多态性的关联研究.中国神经精神疾病杂志;2001,27:296-298.
[49]陶明,施慎逊,顾牛范.5-羟色胺受体的研究现状.中华精神科杂志;1998,31(3)184-186.
[50]Clark MS,McDevitt RA,Neumaier JF.Quantitative mapping of tryptophan hydroxylase-2,5-HT1A,5-HT1B,and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei.J Comp Neurol,2006,498(5):611-623.
[51]Rujescu D,Giegling I,Sato T,et al.Lack of association between serotonin5-HT1B receptor gene polymorphism and suicidal behavior.Am J Med Genet B Neuropsychiatr Genet,2003,116(1):69-71.
[52]Turecki G,Sequeira A,Gingras Y,et al.Suicide and serotonin:study of variation at seven serotonin receptor genes in suicide completers.Am J Med Genet B Neuropsychiatr Genet,2003,118(1):36-40.
[53]Nelson JC.A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression.Biol Psychiatry,1999,46(9):1301-1308.
[54]Blier P,Saint-Andre E,Hebert C,et al.Effects of different does of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.Int J Neuropsychopharmacol,2007,10(1):41-50.
[55]王传跃,翟屹民,翁永振,等.安非他酮与阿密替林治疗抑郁障碍的双盲对照研究.中华精神科杂志;2006,39(3)169-173
[56]DeBattista C,Solvason HB,Pokier J,et al.A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergicantidepressants.JClin Psychopharmacol.2003,23(1):27-30.
[57]Bauer M,Adli M,Baethge C,et al.Lithium augmentation therapy in refractory depression:clinical evidence and neurobiological mechanisms.Canadian Journal of Psychiatry,2003,48(7):440-448.
[58]Bauer M,Dopfmer S.Lithium augmentation in treatment-resistant depression:meta-analysis of placebo-controlled studies.Journal of Clinical Psychopharmacology,1999,19(5):427-434.
[59]Joffe RT,Singer W,Levitt AJ,et al.A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.Arch Gen Psychiatry,1993,50(5):387-393.
[60]张唯扬,郭先健.钙信号基本单位和特征的研究进展.生理科学进展,2000,31(2):109-114.
[61]刘景生.细胞信息与调控.第二版,北京:北京协和医科大学出版社,2004:283-338.
[62]I.B.莱维坦,L.K.卡茨玛克.(舒斯云,包新民译).神经元:细胞和分子生物学.第一版,北京:科学出版社,2001:185-205.
[63]刘煜,赵晓航,吴文.钙/钙调蛋白依赖性丝氨酸蛋白激酶的结构和功能.生物化学和生物物理进展,2002,29:14-18.
[64]许绍芬.神经生物学.第二版,上海:上海医科大学出版社,1999,185-200.
[65]鞠躬,吕国蔚,王百忍.神经生物学.第一版,北京:人民卫生出版社,2004:159-176.
[66]胡健,胡友梅.G蛋白亚单位基因家族研究进展.生理科学进展,2003,34(2):131-135
[67]Hepler JR.Emerging roles for RGS proteins in cell signalling.Trends Pharmacol Sci,1999,20(9):376-382.
[68]陈紫薇,杨奎,王韵,等.G蛋白偶联受体失敏及内吞相关蛋白的研究进展.生理科学进展,2001,32(1):55-58.
[69]鲍国斌,濮璐,,裴钢.G蛋白对离子通道的调控.生命的化学,1998,18(4):19-21.
[70]杜延顺,黄秉仁.G蛋白信号调节因子的结构分类与功能.生理科学,2005,36(3):215-219.
[71]喻东山.心境稳定剂的作用机制.国外医学精神病学分册,2000,27(4):211-215.
[72]Avissar S,Nechamkin Y,Barki-Harrington L,et al.Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent.Affect Disord,1997,43(2):85-93.
[73]Avissar S,Nechamkin Y,Roitman G,et al.Dynamics of ECT normalization of low G protein function and immunoreactivity in mononuclear leukocytes of patients with major depression.Am J Psychiatry,1998,155(5):666-671.
[74]Alda M,Keller D,Grof E,et al.Is lithium response related to G(s)alpha levels in transformed lymphoblasts from subjects with bipolar disorder? J Affect Disord,2001,65(2):117-122.
[75]CelanoE,TiraboschiE,Consogno E,et al.Selective regulation of presynaptic calcium/calmodulin-dependent protein kinase Ⅱ by psychotropic drugs.Biol psychiatry, 2003,53(3):442-449.
[76] Vargens DD, Almendra L, Struchiner CJ, et al. Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol, 2008,64(3): 253-256.
[77] Young LT, Li PP, Kamble A, et al. Lack of effect of antidepressants on mononuclear leukocyte G-protein levels or function in depressed outpatients.J Affect Disord, 1996, 39(3): 201-207.
[78] Avissar S, Nechamkin Y, Barki-Harrington L, et al.Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. J Affect Disord, 1997, 43 (2): 85-93.
[79] Young LT, Li PP, Kamble A, et al. Mononuclear leukocyte levels of G proteins in depressed patients with bipolar disorder or major depressive disorder.Am J Psychiatry, 1994,151(4): 594-596.
[80] Karege F, Bovier P, Stepanian R, et al.The effect of clinical outcome on platelet G proteins of major depressed patients .Eur Neuropsychopharmacol, 1998,8(2):89-94.
[81] Garcia-Sevilla JA, Ventayol P, Perez V, et al. Regulation of platelet alpha 2A-adrenoceptors, Gi proteins and receptor kinases in major depressionxffects of mirtazapine treatment. Neuropsychopharmacology, 2004,29(3):580-588.
[82] Hahn CG, Umapathy, Wang HY, et al. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.J Psychiatr Res, 2005, 39(4): 355-363.
[83] Bishop JR, Moline J, Ellingrod VL, et al. Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-Associated sexual side-effects. Neuropsychopharmacology, 2006, 31(10): 2281-2288.
[84] Johansson C, Willeit M, Aron L,et al .Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism. Biol Psychiatry, 2004, 55(3):317-319.
[85] Willeit M, Praschak-Rieder N, Zill P, et al. C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder. Biol Psychiatry, 2003,54(7): 682-686.
[86] Kunugi H, Kato T, Fukuda R, et al. Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders. J Neural Transm, 2002,109(2):213-218.
[87] 江开达．精神药理学．第一版．人民卫生出版社,北京2007
[88] Lowther S,Katona CL,Crompton MR, et al. Brain [3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants.Brain Res, 1997,758(1-2): 223-228.
[89] Mooney JJ, Samson JA,McHale NL, et al. Signal transduction by platelet adenylate cyclase: alterations in depressed patients may reflect impairment in. the coordinated integration of cellular signals (coincidence detection). Biol Psychiatry,1998,43(8):574-583.
[90] Newman ME, Lerer B, Lichtenberg P, et al. Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology (Berl), 1992,109(2):231-234.
[91] van der Stelt HM, Broersen LM, Olivier B, et al Effects of dietary tryptophan variations on extracellular serotonin in the dorsal hippocampus of rats. Psychopharmacology (Berl).2004,172(2):137-144.
[92] Menninger JA, Baron AE, Conigrave KM, et al. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism. Alcohol Clin Exp Res. 2000,24(6):810-821.
[93] Vetulani J, Sulser E Action of Various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in cimbic forebrain. Nature, 1975, 257(5526): 495-496.
[94] Xu Z, Seidler FJ, Cousins MM, et al. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res. 2002, 951(2) :280-292.
[95]李海燕,周东丰.电针和氟西汀治疗抑郁症对血小板蛋白激酶C的影响.中国心理卫生杂志,2004,18(10):688-691.
[96]许晶,刘晶.行为缺损抑郁大鼠脑环磷酸腺苷含量及蛋白激酶C表达的变化.中华精神科杂志,2002,35(3):173-176.
[97]许晶,马丽珍,王俊平.,抑郁症患者血小板蛋白激酶C水平的变化.临床精神医学杂志,2003,13(5):258-259.
[98]Hahn CG,Umapathy,Wang HY,et al.Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients.J Psychiatr Res,2005,39(4):355-363.
[99]Hahn CG,Friedman E.Abnormalities in protein kinase C signaling and the patho- physiology of bipolar disorder.Bipolar Disord,1999,1(2):81-86.
[100]Duman R,Malberg J,Nakagawa S,et al.Neuronal plasticity and survival in mood disorders.Biol Psychiatry,2000,48(8):732-739.
[101]Nibuya M,Nestler EJ,Duman RS.Chronic antidepressant administration increases the expression of cAMP response element binding protein(CREB)in rat hippocampus.Neurosci,1996,16(7):2365-2372.
[102]Thome J,Sakai N,Shin K,et al.cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.Neurosci,2000,20(11):4030-4036.
[103]Blom J,Tascedda F,Carra S,et al.Altered regulation of CREB by chronic antidepressant administration in the brain of transgenic mice with impaired glucocorticoid receptor function.Neuropsychopharmacology,2002,26(5):605-614.
[104]Shieh PB,Hu SC,Bobb K,et al.Identification of a signaling pathway involved in calcium regulation of BDNF expression.Neuron,1998,20(4):727-740.
[105]Tao X,Finkbeiner S,Arnold DB,et al.Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.Neuron,1998,20(4):709-726.
[106]Nestler E,Aghajanian GK.Molecular and cellular basis of addiction.Science,1997,278(5335):58-63.
[107] Milner B, Squire LR, Kandel ER. Cognitive neuroscience and the study of memory.Neuron,1998, 20(3):445-468.
[108] Silva A, Kogan JH, Frankland PW, et al. CREB and memory. Annu Rev Neurosci,1998,21:127-148.
[109] Chen A-H, Shirayama Y, Shin KH, et al. Expression of the cAMP response element binding protein (CREB) in hippocampus produces antidepressant effect.Biol Psychiatry 2001,49(9):753-762.
[110] Dowlatshahi D, MacQueen GM, Wang JF, et al. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet, 1998, 352(9142): 1754-1755.
[111] Rossby S, Manier DH, Liang S, et al.Venlafaxine; pharmacological actions. beyond aminergic receptors.Int J Neuropsychopharmacol,1999, 2(1):1-8.
[112] Manier D, Shelton RC, Sulser F. Noradrenergic antidepressants: does chronic treatment increase or decrease nuclear CREB-P?.J Neural Transm, 2002,109(1):91-99.
[113] Pliakas A, Carlson RR, Neve RL, et al. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated CREB expression in the nucleus accumbens. J Neurosci ,2001,21(18):7397-7403.
[114] Conti A, Cryan JF, Dalvi A, et al. cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.J Neurosci ,2002,22(8):3262-3268.
[1]舒斯云,包新民译I.B.莱维坦,L.K.卡茨玛克.著神经元:细胞和分子生物学[M]第一版,北京:科学出版社,2001:185-205.
[2]刘景生.细胞信息与调控[M].第二版,北京:北京协和医科大学出版社,2004:283-338.
[3]Mitchell PB,Manji HK.High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder[J].Am J Psychiatry,1997,154(2):218-223.
[4]A lda M,et,al,Is lithium response related to Gs alpha levels in transformed lymphoblasts form subjects with bipolar disorder? Affective Disord 2001;65(2):117-122
[5]Celaano E,et,al.Selectively regulartion of presynaptic calcium lcalmodulin-dependent predent protein dinase Ⅱ by psychopic drugs.biol psychiatry.2003.53(3)442-449
[6]Schreiber G,Avissar S.G proteins as a biochemical tool for diagnosis and monitoring treatments of mental disorders[J].Isr Med Assoc J,2002:86-91.
[7]Levinson DF.The genetics of depression:a review.Biol Psychiatry.2006 Jul 15;60(2):84-92.
[8].Hayden EP,Nurnberger JI Jr.Molecular genetics of bipolar disorder.Genes Brain Behav.2006;5(1):85-95.
[9]胡健,胡友梅.G蛋白亚单位基因家族研究进展.[J]生理科学进展,2003,34(2):131-135.
[10]Willeit M,Praschak-Rieder N,Zill P,et al.C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder[J].Biol Psychiatry.2003 Oct 1;54(7):682-686.
[11]Bishop JR,Moline J,Ellingrod VL,et al.Serotonin 2A -1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-Associated sexual side-effects[J].Neuropsychopharmacology,2006,31(10):2281-2288.
[12] Tsiouris SJ, Breschel TS, Xu i,et al. Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder[J]. Am J Med Genet,1996,67(5):491-494.
[13] Ram A, Guedj F, Cravchik A,et al. No abnormality in the gene for the G protein stimulatory alpha subunit in patients with bipolar disorder [J]. Arch Gen Psychiatry, 1997,54(1):44-48.
[14] Saito T, Papolos DF, Chernak D,et al. Analysis of GNAZ gene polymorphism in bipolar affective disorder[J]. Am J Med Gene, 1999,88(4):324-328.
[15] Zill P, Engel R, Baghai TC,et al.Analysis of polymorphisms in the olfactory G-protein Golf in major depression[J]. Psychiatr Genet, 2002,12(1):17-22.
[16] Zill P, Baghai TC, Zwanzger P,et al. Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression[J]. Am J Med Genet,2002,114(5):530-532.
[17] Zill P, Malitas PN, Bondy B,et al. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients[J]. Psychiatr Genet, 2003,13(2):65-69.
[18] Spleiss O, van Calker D .Abnormal G protein alpha(s) - and alpha(i)-subunit mRNA expression in bipolar affective disorder[J].Mol Psychiatry, 1998,3(6):512- 520.
[19] Zill P, Baghai TC, Zwanzger Y,et al. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment[J]. Neuroreport, 2000,11(9):1893-1897.
[20] Willeit M, Praschak-Rieder N, Zill ?,et al. C825T polymorphism in the G protein beta3-subunit gene is associated with seasonal affective disorder [J]. Biol Psychiatry. 2003;54(7):682-686.
[21] Lee HJ, Cha JH, Ham BJ,et al. Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders[J]. Pharmacogenomics J,2004,4(1):29-33.
[22] Serretti A, Lorenzi C, Cusin C,et al. SSRIs antidepressant activity is influenced by G beta 3 variants[J]. Eur Neuropsychopharmacol. 2003,13(2):117-122.
[23] Joyce PR,Mulder RT,Luty SE,et al. Age-dependent antidepressant pharmaco- genomics:polymorphisms of the serotonin transporter and G protein beta3subunit as predictors of response to fluoxetine and nortriptyline[J].Int J Neuropsy- chopharmacol,2003,6(4):339-346.
[24]Exton MS,Artz M,Siffert W,et al.G protein beta3 subunit 825T allele is associated with depression in young,healthy subjects[J].Neuroreport,2003,14(3):531-533.
[25]Johansson C,Willeit M,Aron L,et al.Seasonal affective disorder and the G-protein beta-3-subunit C825T polymorphism[J].Biol Psychiatry,2004,55(3):317-319.
[26]Kunugi H,Kato T,Fukuda R,et al.Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders[J].J Neural Transm,2002,109(2):213-218.
[27]Lin CN,Tsai SJ,Hong CJ.Association analysis of a functional G protein beta3subunit gene polymorphism(C825T)in mood disorders[J].Neuropsychobiology,2001,44(3):118-121.
[27]肖红,姚毁,郭素婉,等.G蛋白β3亚基基因C825T多态性与抑郁症及SSRI 和SNRI类抗抑郁药的关系.中国临床药理学杂志2002;18(6)414-416。
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |